Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Head and Neck Cancer

  Free Subscription


Articles published in BMC Cancer

Retrieve available abstracts of 475 articles:
HTML format



Single Articles


    July 2021
  1. CHEN W, Luo YK, Zhang Y, Song Q, et al
    Ultrasound-guided implantation of radioactive (125)I seed in radioiodine refractory differentiated thyroid carcinoma.
    BMC Cancer. 2021;21:834.
    PubMed     Abstract available


  2. ZHU C, Gu L, Liu Z, Li J, et al
    Correlation between vascular endothelial growth factor pathway and immune microenvironment in head and neck squamous cell carcinoma.
    BMC Cancer. 2021;21:836.
    PubMed     Abstract available


    June 2021
  3. ITO T, Tsukahara K, Sato H, Shimizu A, et al
    Changes in carnitine levels through induction chemotherapy in head and neck cancer patients as a potential cause of therapy-related malaise.
    BMC Cancer. 2021;21:742.
    PubMed     Abstract available


  4. MIYAWAKI Y, Sato H, Oya S, Sugita H, et al
    Clinical impact of abdominal versus mediastinal metastases as a prognostic factor for poor outcomes following esophageal cancer surgery: a retrospective study.
    BMC Cancer. 2021;21:725.
    PubMed     Abstract available


  5. DRAGAN T, Duprez F, Van Gossum A, Gulyban A, et al
    Prophylactic gastrostomy in locally advanced head and neck cancer: results of a national survey among radiation oncologists.
    BMC Cancer. 2021;21:656.
    PubMed     Abstract available


  6. HOXHAJ I, Vukovic V, Boccia S, Pastorino R, et al
    Single nucleotide polymorphisms and the risk of developing a second primary cancer among head and neck cancer patients: a systematic literature review and meta-analysis.
    BMC Cancer. 2021;21:660.
    PubMed     Abstract available


  7. CHEN WJ, Xu WN, Wang HY, Chen XX, et al
    Plasma Epstein-Barr virus DNA and risk of nasopharyngeal carcinoma in a prospective seropositive population.
    BMC Cancer. 2021;21:651.
    PubMed     Abstract available


    May 2021
  8. LIU W, Yu B, Luo Y, Li J, et al
    Survival benefit of induction chemotherapy for locally advanced nasopharyngeal carcinoma: prognosis based on a new risk estimation model.
    BMC Cancer. 2021;21:639.
    PubMed     Abstract available


  9. LI X, Fang Q, Du W, Zhang X, et al
    Induction chemotherapy combined with immunotherapy in locally advanced head and neck squamous cell carcinoma.
    BMC Cancer. 2021;21:622.
    PubMed     Abstract available


  10. QUINTANILHA JCF, Cursino MA, Borges JB, Torso NG, et al
    MiR-3168, miR-6125, and miR-4718 as potential predictors of cisplatin-induced nephrotoxicity in patients with head and neck cancer.
    BMC Cancer. 2021;21:575.
    PubMed     Abstract available


  11. BEYENE ET, Ketema SG, Alebachew AN, Saleh MY, et al
    Descriptive epidemiology of nasopharyngeal carcinoma at Tikur Anbessa Hospital, Ethiopia.
    BMC Cancer. 2021;21:540.
    PubMed     Abstract available


  12. YANG JH, Sun XS, Xiao BB, Liu LT, et al
    Subdivision of de-novo metastatic nasopharyngeal carcinoma based on tumor burden and pretreatment EBV DNA for therapeutic guidance of locoregional radiotherapy.
    BMC Cancer. 2021;21:534.
    PubMed     Abstract available


  13. XU Y, Wu Z, Ye W, Xiao Y, et al
    Prognostic value of serum uric acid and tumor response to induction chemotherapy in locally advanced nasopharyngeal carcinoma.
    BMC Cancer. 2021;21:519.
    PubMed     Abstract available


  14. ARSA L, Siripoon T, Trachu N, Foyhirun S, et al
    Discrepancy in p16 expression in patients with HPV-associated head and neck squamous cell carcinoma in Thailand: clinical characteristics and survival outcomes.
    BMC Cancer. 2021;21:504.
    PubMed     Abstract available


    April 2021
  15. ALMANGUSH A, Alabi RO, Troiano G, Coletta RD, et al
    Clinical significance of tumor-stroma ratio in head and neck cancer: a systematic review and meta-analysis.
    BMC Cancer. 2021;21:480.
    PubMed     Abstract available


  16. ZHANG X, Song X, Lai Y, Zhu B, et al
    Identification of key pseudogenes in nasopharyngeal carcinoma based on RNA-Seq analysis.
    BMC Cancer. 2021;21:483.
    PubMed     Abstract available


  17. KUNZ V, Wichmann G, Lehmann-Laue A, Mehnert-Theuerkauf A, et al
    Screening for distress, related problems and perceived need for psycho-oncological support in head and neck squamous cell carcinoma (HNSCC) patients: a retrospective cohort study.
    BMC Cancer. 2021;21:478.
    PubMed     Abstract available


  18. WONG TJ, Li Q, Dodd V, Wang W, et al
    Oral cancer knowledge and screening behavior among smokers and non-smokers in rural communities.
    BMC Cancer. 2021;21:430.
    PubMed     Abstract available


  19. DUAN X, Shang X, Yue J, Ma Z, et al
    A nomogram to predict lymph node metastasis risk for early esophageal squamous cell carcinoma.
    BMC Cancer. 2021;21:431.
    PubMed     Abstract available


  20. ZHOU LQ, Hu Y, Xiao HJ
    The prognostic significance of survivin expression in patients with HNSCC: a systematic review and meta-analysis.
    BMC Cancer. 2021;21:424.
    PubMed     Abstract available


  21. DING Y, Jiang R, Chen Y, Jing J, et al
    Comparing the characteristics and predicting the survival of patients with head and neck melanoma versus body melanoma: a population-based study.
    BMC Cancer. 2021;21:420.
    PubMed     Abstract available


  22. WEI M, Zhao L, Lv J, Li X, et al
    The mediation effect of serum metabolites on the relationship between long-term smoking exposure and esophageal squamous cell carcinoma.
    BMC Cancer. 2021;21:415.
    PubMed     Abstract available


  23. BOGUSZEWICZ L, Bielen A, Jarczewski JD, Ciszek M, et al
    Molecular response to induction chemotherapy and its correlation with treatment outcome in head and neck cancer patients by means of NMR-based metabolomics.
    BMC Cancer. 2021;21:410.
    PubMed     Abstract available


  24. SAENTHAVEESUK P, Yang L, Zeng B, Xu M, et al
    Development and validation of multiparametric MRI-based nomogram for predicting occult metastasis risk in early tongue squamous cell carcinoma.
    BMC Cancer. 2021;21:408.
    PubMed     Abstract available


  25. WANG Y, Zhang X, Zhang X, Liu-Helmersson J, et al
    Prognostic value of the extent of lymphadenectomy for esophageal cancer-specific survival among T1 patients.
    BMC Cancer. 2021;21:403.
    PubMed     Abstract available


  26. ZHOU Z, Wu W, Li J, Liu C, et al
    Bioinformatics analysis of the expression and role of microRNA-221-3p in head and neck squamous cell carcinoma.
    BMC Cancer. 2021;21:395.
    PubMed     Abstract available


  27. BERNADACH M, Lapeyre M, Dillies AF, Miroir J, et al
    Predictive factors of toxicity of TPF induction chemotherapy for locally advanced head and neck cancers.
    BMC Cancer. 2021;21:360.
    PubMed     Abstract available


  28. NIE Z, Zhao P, Shang Y, Sun B, et al
    Nomograms to predict the prognosis in locally advanced oral squamous cell carcinoma after curative resection.
    BMC Cancer. 2021;21:372.
    PubMed     Abstract available


  29. ZHU Q, Xu D
    Correlation between preoperative ultrasonic features of medullary thyroid carcinoma and postoperative recurrence.
    BMC Cancer. 2021;21:344.
    PubMed     Abstract available


  30. ZHENG W, Chen C, Yu J, Jin C, et al
    An energy metabolism-based eight-gene signature correlates with the clinical outcome of esophagus carcinoma.
    BMC Cancer. 2021;21:345.
    PubMed     Abstract available


    March 2021
  31. YOSHIMURA S, Mori K, Ri M, Aikou S, et al
    Comparison of short-term outcomes between transthoracic and robot-assisted transmediastinal radical surgery for esophageal cancer: a prospective study.
    BMC Cancer. 2021;21:338.
    PubMed     Abstract available


  32. YANG X, Suo C, Zhang T, Yin X, et al
    A nomogram for screening esophageal squamous cell carcinoma based on environmental risk factors in a high-incidence area of China: a population-based case-control study.
    BMC Cancer. 2021;21:343.
    PubMed     Abstract available


  33. HE T, Yan RN, Chen HY, Zeng YY, et al
    Comparing the 7th and 8th editions of UICC/AJCC staging system for nasopharyngeal carcinoma in the IMRT era.
    BMC Cancer. 2021;21:327.
    PubMed     Abstract available


  34. CHOI KH, Song JH, Park EY, Hong JH, et al
    Analysis of PET parameters as prognosticators of survival and tumor extent in Oropharyngeal Cancer treated with surgery and postoperative radiotherapy.
    BMC Cancer. 2021;21:317.
    PubMed     Abstract available


  35. PHAM DX, Nguyen HD, Phung AHT, Bui TD, et al
    Trends in incidence and histological pattern of thyroid cancer in Ho Chi Minh City, Vietnam (1996-2015): a population-based study.
    BMC Cancer. 2021;21:296.
    PubMed     Abstract available


  36. LIU Z, Cheng C, Luo X, Xia Q, et al
    Retraction Note: CDK4 and miR-15a comprise an abnormal automodulatory feedback loop stimulating the pathogenesis and inducing chemotherapy resistance in nasopharyngeal carcinoma.
    BMC Cancer. 2021;21:273.
    PubMed    


  37. LI C, Tao C, Bai T, Li Z, et al
    Beam complexity and monitor unit efficiency comparison in two different volumetric modulated arc therapy delivery systems using automated planning.
    BMC Cancer. 2021;21:261.
    PubMed     Abstract available


  38. CHOI CK, Yang J, Kweon SS, Cho SH, et al
    Association between ALDH2 polymorphism and esophageal cancer risk in South Koreans: a case-control study.
    BMC Cancer. 2021;21:254.
    PubMed     Abstract available


  39. WANG Y, Wang M, Tang Y, Sun B, et al
    Perioperative mortality of head and neck cancers.
    BMC Cancer. 2021;21:256.
    PubMed     Abstract available


  40. ZHANG S, Zhang R, Wang C, Gong W, et al
    Central neck lymph node metastasis in oral squamous cell carcinoma at the floor of mouth.
    BMC Cancer. 2021;21:225.
    PubMed     Abstract available


  41. ZOU Y, Zhang H, Li W, Guo Y, et al
    Prediction of ipsilateral lateral cervical lymph node metastasis in papillary thyroid carcinoma: a combined dual-energy CT and thyroid function indicators study.
    BMC Cancer. 2021;21:221.
    PubMed     Abstract available


    February 2021
  42. CHIAMULERA MMA, Zancan CB, Remor AP, Cordeiro MF, et al
    Salivary cytokines as biomarkers of oral cancer: a systematic review and meta-analysis.
    BMC Cancer. 2021;21:205.
    PubMed     Abstract available


  43. CHOI SY, Lee E, Kim E, Chung MK, et al
    Clinical outcomes of bulky parotid gland cancers: need for self-examination and screening program for early diagnosis of parotid tumors.
    BMC Cancer. 2021;21:178.
    PubMed     Abstract available


  44. ABDEL HAMID HM, Darwish ZE, Elsheikh SM, Mourad GM, et al
    Following cytotoxic nanoconjugates from injection to halting the cell cycle machinery and its therapeutic implications in oral cancer.
    BMC Cancer. 2021;21:170.
    PubMed     Abstract available


  45. CHEN D, Wang W, Mo J, Ren Q, et al
    Minimal invasive versus open esophagectomy for patients with esophageal squamous cell carcinoma after neoadjuvant treatments.
    BMC Cancer. 2021;21:145.
    PubMed     Abstract available


  46. WENTER V, Albert NL, Ahmaddy F, Unterrainer M, et al
    The diagnostic challenge of coexistent sarcoidosis and thyroid cancer - a retrospective study.
    BMC Cancer. 2021;21:139.
    PubMed     Abstract available


  47. LIANG YJ, Mei XY, Zeng B, Zhang SE, et al
    Prognostic role of preoperative D-dimer, fibrinogen and platelet levels in patients with oral squamous cell carcinoma.
    BMC Cancer. 2021;21:122.
    PubMed     Abstract available


  48. ZHANG Z, Chen C, Fang Y, Li S, et al
    Development of a prognostic signature for esophageal cancer based on nine immune related genes.
    BMC Cancer. 2021;21:113.
    PubMed     Abstract available


  49. WANG X, Wang H, Wang H, Huang J, et al
    Prognostic value of visual residual tumour cells (VRTC) for patients with esophageal squamous cell carcinomas after neoadjuvant therapy followed by surgery.
    BMC Cancer. 2021;21:111.
    PubMed     Abstract available


    January 2021
  50. HAMMERMULLER C, Hinz A, Dietz A, Wichmann G, et al
    Depression, anxiety, fatigue, and quality of life in a large sample of patients suffering from head and neck cancer in comparison with the general population.
    BMC Cancer. 2021;21:94.
    PubMed     Abstract available


  51. KONDO S, Hirakawa H, Ikegami T, Uehara T, et al
    Raptor and rictor expression in patients with human papillomavirus-related oropharyngeal squamous cell carcinoma.
    BMC Cancer. 2021;21:87.
    PubMed     Abstract available


  52. SOLIS-PAZMINO P, Salazar-Vega J, Lincango-Naranjo E, Garcia C, et al
    Thyroid cancer overdiagnosis and overtreatment: a cross- sectional study at a thyroid cancer referral center in Ecuador.
    BMC Cancer. 2021;21:42.
    PubMed     Abstract available


  53. ZHAO F, Lu RX, Liu JY, Fan J, et al
    Development and validation of nomograms to intraoperatively predict metastatic patterns in regional lymph nodes in patients diagnosed with esophageal cancer.
    BMC Cancer. 2021;21:22.
    PubMed     Abstract available


    December 2020
  54. MUKHOPADHYAY S, Ghosh S, Das D, Arun P, et al
    Application of Random Forest and data integration identifies three dysregulated genes and enrichment of Central Carbon Metabolism pathway in Oral Cancer.
    BMC Cancer. 2020;20:1219.
    PubMed     Abstract available


  55. KATAGIRI T, Ohyama Y, Miyamoto H, Egawa Y, et al
    Pathological responses to low-dose irradiation and Pepleomycin in Oral squamous cell carcinoma are predictive of Locoregional control.
    BMC Cancer. 2020;20:1216.
    PubMed     Abstract available


  56. ZHANG J, Li H, Zhou L, Yu L, et al
    Modified nodal stage of esophageal cancer based on the evaluation of the hazard rate of the negative and positive lymph node.
    BMC Cancer. 2020;20:1200.
    PubMed     Abstract available


  57. DATAR S, Cabanillas M, Dadu R, Ost D, et al
    Pulmonary cavitation in patients with thyroid cancer receiving antiangiogenic agents.
    BMC Cancer. 2020;20:1181.
    PubMed     Abstract available


  58. HO SY, Tsang RKY
    Value of oesophagoscopy and bronchoscopy in diagnosis of synchronous malignancies in patients with head and neck squamous cell carcinomas.
    BMC Cancer. 2020;20:1172.
    PubMed     Abstract available


    November 2020
  59. KALISZEWSKI K, Diakowska D, Nowak L, Wojtczak B, et al
    The age threshold of the 8th edition AJCC classification is useful for indicating patients with aggressive papillary thyroid cancer in clinical practice.
    BMC Cancer. 2020;20:1166.
    PubMed     Abstract available


  60. XIE Z, Li X, He Y, Wu S, et al
    Analysis of the expression and potential molecular mechanism of interleukin-1 receptor antagonist (IL1RN) in papillary thyroid cancer via bioinformatics methods.
    BMC Cancer. 2020;20:1143.
    PubMed     Abstract available


  61. ZHU K, Lin R, Zhang Z, Chen H, et al
    Impact of prior cancer history on the survival of patients with larynx cancer.
    BMC Cancer. 2020;20:1137.
    PubMed     Abstract available


  62. KAGAMI T, Yamade M, Suzuki T, Uotani T, et al
    The first evidence for SLFN11 expression as an independent prognostic factor for patients with esophageal cancer after chemoradiotherapy.
    BMC Cancer. 2020;20:1123.
    PubMed     Abstract available


  63. KANG HY, Kim I, Kim YY, Bahk J, et al
    Income differences in screening, incidence, postoperative complications, and mortality of thyroid cancer in South Korea: a national population-based time trend study.
    BMC Cancer. 2020;20:1096.
    PubMed     Abstract available


  64. TONG Y, Hu C, Huang Z, Fan Z, et al
    Novel nomogram to predict risk of bone metastasis in newly diagnosed thyroid carcinoma: a population-based study.
    BMC Cancer. 2020;20:1055.
    PubMed     Abstract available


    October 2020
  65. GU B, Fang Q, Wu Y, Du W, et al
    Impact of submandibular gland preservation in neck management of early-stage buccal squamous cell carcinoma on locoregional control and disease-specific survival.
    BMC Cancer. 2020;20:1034.
    PubMed     Abstract available


  66. ZHANG F, Liu Y, Yang Y, Yang K, et al
    Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
    BMC Cancer. 2020;20:1015.
    PubMed     Abstract available


  67. HOSHINO I, Nabeya Y, Takiguchi N, Gunji H, et al
    Inducing multiple antibodies to treat squamous cell esophageal carcinoma.
    BMC Cancer. 2020;20:1007.
    PubMed     Abstract available


  68. YANG J, Shang J, Song Q, Yang Z, et al
    ECCDIA: an interactive web tool for the comprehensive analysis of clinical and survival data of esophageal cancer patients.
    BMC Cancer. 2020;20:985.
    PubMed     Abstract available


  69. AN YZ, Cho E, Ling J, Zhang X, et al
    The Axin2-snail axis promotes bone invasion by activating cancer-associated fibroblasts in oral squamous cell carcinoma.
    BMC Cancer. 2020;20:987.
    PubMed     Abstract available


  70. ZHAO S, Qi W, Chen J
    Role of a multidisciplinary team in administering radiotherapy for esophageal cancer.
    BMC Cancer. 2020;20:974.
    PubMed     Abstract available


  71. ZHU L, Dong L, Feng M, Yang F, et al
    Profiles of autophagy-related genes in esophageal adenocarcinoma.
    BMC Cancer. 2020;20:943.
    PubMed     Abstract available


    September 2020
  72. HECHT M, Hahn D, Wolber P, Hautmann MG, et al
    Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancer.
    BMC Cancer. 2020;20:933.
    PubMed     Abstract available


  73. FAN C, Wang J, Tang Y, Zhang S, et al
    Upregulation of long non-coding RNA LOC284454 may serve as a new serum diagnostic biomarker for head and neck cancers.
    BMC Cancer. 2020;20:917.
    PubMed     Abstract available


  74. ELHALAWANI H, Mohamed ASR, Elgohari B, Lin TA, et al
    Tobacco exposure as a major modifier of oncologic outcomes in human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma.
    BMC Cancer. 2020;20:912.
    PubMed     Abstract available


  75. GAO LR, Wang X, Han W, Deng W, et al
    A multicenter prospective phase III clinical randomized study of simultaneous integrated boost intensity-modulated radiotherapy with or without concurrent chemotherapy in patients with esophageal cancer: 3JECROG P-02 study protocol.
    BMC Cancer. 2020;20:901.
    PubMed     Abstract available


  76. IZKHAKOV E, Keinan-Boker L, Barchana M, Shacham Y, et al
    Long-term all-cause mortality and its association with cardiovascular risk factors in thyroid cancer survivors: an Israeli population-based study.
    BMC Cancer. 2020;20:892.
    PubMed     Abstract available


  77. LORENZEN S, Biederstadt A, Ronellenfitsch U, Reissfelder C, et al
    RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction - a randomized phase III joint study of the AIO, ARO and DGAV.
    BMC Cancer. 2020;20:886.
    PubMed     Abstract available


  78. CHANG X, Deng L, Ni W, Li C, et al
    Salvage chemoradiation therapy for recurrence after radical surgery or palliative surgery in esophageal cancer patients: a prospective, multicenter clinical trial protocol.
    BMC Cancer. 2020;20:877.
    PubMed     Abstract available


  79. YOON JY, Brezden-Masley C, Streutker CJ
    Lgr5 and stem/progenitor gene expression in gastric/gastroesophageal junction carcinoma - significance of potentially retained stemness.
    BMC Cancer. 2020;20:860.
    PubMed     Abstract available


  80. ALMANGUSH A, Makitie AA, Hagstrom J, Haglund C, et al
    Cell-in-cell phenomenon associates with aggressive characteristics and cancer-related mortality in early oral tongue cancer.
    BMC Cancer. 2020;20:843.
    PubMed     Abstract available


  81. ZHANG Y, Wang J, Dai N, Han P, et al
    Alteration of plasma metabolites associated with chemoradiosensitivity in esophageal squamous cell carcinoma via untargeted metabolomics approach.
    BMC Cancer. 2020;20:835.
    PubMed     Abstract available


  82. HSIEH CY, Lein MY, Yang SN, Wang YC, et al
    Dose-dense TPF induction chemotherapy for locally advanced head and neck cancer: a phase II study.
    BMC Cancer. 2020;20:832.
    PubMed     Abstract available


    August 2020
  83. LEE YG, Kang EJ, Keam B, Choi JH, et al
    Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: a nationwide retrospective cohort study (KCSG HN13-01).
    BMC Cancer. 2020;20:813.
    PubMed     Abstract available


  84. ZHANG B, Gao S, Li R, Li Y, et al
    Tissue mechanics and expression of TROP2 in oral squamous cell carcinoma with varying differentiation.
    BMC Cancer. 2020;20:815.
    PubMed     Abstract available


  85. TU XP, Li H, Chen LS, Luo XN, et al
    OTX1 exerts an oncogenic role and is negatively regulated by miR129-5p in laryngeal squamous cell carcinoma.
    BMC Cancer. 2020;20:794.
    PubMed     Abstract available


  86. ZENG H, Song X, Ji J, Chen L, et al
    HPV infection related immune infiltration gene associated therapeutic strategy and clinical outcome in HNSCC.
    BMC Cancer. 2020;20:796.
    PubMed     Abstract available


  87. CHEN C, Chen S, Cao H, Wang J, et al
    Prognostic significance of autophagy-related genes within esophageal carcinoma.
    BMC Cancer. 2020;20:797.
    PubMed     Abstract available


  88. ZHAO J, Wen J, Wang S, Yao J, et al
    Association between adipokines and thyroid carcinoma: a meta-analysis of case-control studies.
    BMC Cancer. 2020;20:788.
    PubMed     Abstract available


  89. ZARGARI S, Negahban Khameneh S, Rad A, Forghanifard MM, et al
    MEIS1 promotes expression of stem cell markers in esophageal squamous cell carcinoma.
    BMC Cancer. 2020;20:789.
    PubMed     Abstract available


  90. LEERS JM, Knepper L, van der Veen A, Schroder W, et al
    The CARDIA-trial protocol: a multinational, prospective, randomized, clinical trial comparing transthoracic esophagectomy with transhiatal extended gastrectomy in adenocarcinoma of the gastroesophageal junction (GEJ) type II.
    BMC Cancer. 2020;20:781.
    PubMed     Abstract available


  91. CIAPPUCCINI R, Heutte N, Lasne-Cardon A, Saguet-Rysanek V, et al
    Tumor burden of persistent disease in patients with differentiated thyroid cancer: correlation with postoperative risk-stratification and impact on outcome.
    BMC Cancer. 2020;20:765.
    PubMed     Abstract available


  92. WEI H, Yu K, Liu Y, Li L, et al
    Tumor expression of miR-448 is a prognostic marker in oral squamous cell carcinoma.
    BMC Cancer. 2020;20:756.
    PubMed     Abstract available


  93. SHADMANI FK, Farzadfar F, Yoosefi M, Mansori K, et al
    Premature mortality of gastrointestinal cancer in Iran: trends and projections 2001-2030.
    BMC Cancer. 2020;20:752.
    PubMed     Abstract available


  94. JAMIESON L, Forster MD, Zaki K, Mithra S, et al
    Immunotherapy and associated immune-related adverse events at a large UK centre: a mixed methods study.
    BMC Cancer. 2020;20:743.
    PubMed     Abstract available


  95. YANG Y, Li L, Zheng Y, Liu Q, et al
    A prospective, single-arm, phase II clinical trial of intraoperative radiotherapy using a low-energy X-ray source for local advanced Laryngocarcinoma (ILAL): a study protocol.
    BMC Cancer. 2020;20:734.
    PubMed     Abstract available


  96. KIM H, Kwon M, Kim B, Jung HA, et al
    Clinical outcomes of immune checkpoint inhibitors for patients with recurrent or metastatic head and neck cancer: real-world data in Korea.
    BMC Cancer. 2020;20:727.
    PubMed     Abstract available


  97. WANG J, Tian S, Sun J, Zhang J, et al
    The presence of tumour-infiltrating lymphocytes (TILs) and the ratios between different subsets serve as prognostic factors in advanced hypopharyngeal squamous cell carcinoma.
    BMC Cancer. 2020;20:731.
    PubMed     Abstract available


  98. BIAU J, Thivat E, Millardet C, Saroul N, et al
    A multicenter prospective phase II study of postoperative hypofractionated stereotactic body radiotherapy (SBRT) in the treatment of early-stage oropharyngeal and oral cavity cancers with high risk margins: the STEREO POSTOP GORTEC 2017-03 trial.
    BMC Cancer. 2020;20:730.
    PubMed     Abstract available


    July 2020
  99. BUSSMANN L, Laban S, Wittekindt C, Stromberger C, et al
    Comparative effectiveness trial of transoral head and neck surgery followed by adjuvant radio(chemo)therapy versus primary radiochemotherapy for oropharyngeal cancer (TopROC).
    BMC Cancer. 2020;20:701.
    PubMed     Abstract available


  100. BAGHEL SS, Singhal P, Verma N, Sehra R, et al
    Is thyroid excision mandatory with laryngectomy in carcinoma larynx?
    BMC Cancer. 2020;20:700.
    PubMed     Abstract available


  101. JIANG C, Gao H, Zhang L, Li H, et al
    Distribution pattern and prognosis of metastatic lymph nodes in cervical posterior to level V in nasopharyngeal carcinoma patients.
    BMC Cancer. 2020;20:667.
    PubMed     Abstract available


  102. LIN JL, Lin JX, Zheng CH, Li P, et al
    Relationship between aspirin use of esophageal, gastric and colorectal cancer patient survival: a meta-analysis.
    BMC Cancer. 2020;20:638.
    PubMed     Abstract available


  103. LOPEZ GAVILANEZ E, Bautista Litardo N, Navarro Chavez M, Hernandez Bonilla M, et al
    Thyroid cancer in Ecuador.
    BMC Cancer. 2020;20:637.
    PubMed     Abstract available


  104. JIANG X, Huang Z, Sun X, Zheng X, et al
    CCL18-NIR1 promotes oral cancer cell growth and metastasis by activating the JAK2/STAT3 signaling pathway.
    BMC Cancer. 2020;20:632.
    PubMed     Abstract available


  105. YIBULAYIN F, Feng L, Wang M, Lu MM, et al
    Head & neck acinar cell carcinoma: a population-based study using the seer registry.
    BMC Cancer. 2020;20:631.
    PubMed     Abstract available


    June 2020
  106. FENG Y, Yan S, Huang Y, Huang Q, et al
    High expression of RABL6 promotes cell proliferation and predicts poor prognosis in esophageal squamous cell carcinoma.
    BMC Cancer. 2020;20:602.
    PubMed     Abstract available


  107. BISSEY PA, Teng M, Law JH, Shi W, et al
    MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma.
    BMC Cancer. 2020;20:597.
    PubMed     Abstract available


  108. LI G, Qiu B, Huang YX, Doyen J, et al
    Cost-effectiveness analysis of proton beam therapy for treatment decision making in paranasal sinus and nasal cavity cancers in China.
    BMC Cancer. 2020;20:599.
    PubMed     Abstract available


  109. WANG Q, Wu Z, Zhan T, Fang S, et al
    Correction to: Comparison of minimally invasive Ivor Lewis esophagectomy and left transthoracic esophagectomy in esophageal squamous cell carcinoma patients: a propensity score-matched analysis.
    BMC Cancer. 2020;20:593.
    PubMed     Abstract available


  110. LI Y, Wu G, Yang W, Wang X, et al
    Prognostic value of circulating tumor cells detected with the CellSearch system in esophageal cancer patients: a systematic review and meta-analysis.
    BMC Cancer. 2020;20:581.
    PubMed     Abstract available


  111. HASEGAWA T, Iga T, Takeda D, Amano R, et al
    Neutrophil-lymphocyte ratio associated with poor prognosis in oral cancer: a retrospective study.
    BMC Cancer. 2020;20:568.
    PubMed     Abstract available


  112. MORRISSEY ME, Byrne R, Nulty C, McCabe NH, et al
    The tumour microenvironment of the upper and lower gastrointestinal tract differentially influences dendritic cell maturation.
    BMC Cancer. 2020;20:566.
    PubMed     Abstract available


  113. VARDARLI I, Weidemann F, Aboukoura M, Herrmann K, et al
    Longer-term recurrence rate after low versus high dose radioiodine ablation for differentiated thyroid Cancer in low and intermediate risk patients: a meta-analysis.
    BMC Cancer. 2020;20:550.
    PubMed     Abstract available


  114. WANG C, Zhao K, Hu S, Huang Y, et al
    A predictive model for treatment response in patients with locally advanced esophageal squamous cell carcinoma after concurrent chemoradiotherapy: based on SUVmean and NLR.
    BMC Cancer. 2020;20:544.
    PubMed     Abstract available


  115. CHEN PJ, Yap WK, Chang YC, Tseng CK, et al
    Prognostic value of lymph node to primary tumor standardized uptake value ratio in unresectable esophageal cancer.
    BMC Cancer. 2020;20:545.
    PubMed     Abstract available


  116. RICHARDS HS, Blazeby JM, Portal A, Harding R, et al
    A real-time electronic symptom monitoring system for patients after discharge following surgery: a pilot study in cancer-related surgery.
    BMC Cancer. 2020;20:543.
    PubMed     Abstract available


  117. FANG Q, Gao H, Gao Q, Sun J, et al
    Elective neck dissection versus wait-and-see policy in cT1N0 buccal squamous cell carcinoma.
    BMC Cancer. 2020;20:537.
    PubMed     Abstract available


  118. KLEIN NULENT TJW, Valstar MH, Smit LA, Smeele LE, et al
    Prostate-specific membrane antigen (PSMA) expression in adenoid cystic carcinoma of the head and neck.
    BMC Cancer. 2020;20:519.
    PubMed     Abstract available


  119. NGAMPHAIBOON N, Dechaphunkul A, Setakornnukul J, Dechaphunkul T, et al
    Optimal cumulative dose of cisplatin for concurrent chemoradiotherapy among patients with non-metastatic nasopharyngeal carcinoma: a multicenter analysis in Thailand.
    BMC Cancer. 2020;20:518.
    PubMed     Abstract available


  120. SHAH R, Sharma V, Bhat A, Singh H, et al
    MassARRAY analysis of twelve cancer related SNPs in esophageal squamous cell carcinoma in J&K, India.
    BMC Cancer. 2020;20:497.
    PubMed     Abstract available


  121. ZHANG B, Lian Z, Zhong L, Zhang X, et al
    Machine-learning based MRI radiomics models for early detection of radiation-induced brain injury in nasopharyngeal carcinoma.
    BMC Cancer. 2020;20:502.
    PubMed     Abstract available


  122. HUMPHRIES MP, Craig SG, Kacprzyk R, Fisher NC, et al
    The adaptive immune and immune checkpoint landscape of neoadjuvant treated esophageal adenocarcinoma using digital pathology quantitation.
    BMC Cancer. 2020;20:500.
    PubMed     Abstract available


  123. FAHEY PP, Page A, Stone G, Astell-Burt T, et al
    Augmenting cancer registry data with health survey data with no cases in common: the relationship between pre-diagnosis health behaviour and post-diagnosis survival in oesophageal cancer.
    BMC Cancer. 2020;20:496.
    PubMed     Abstract available


  124. TINTELNOT J, Goekkurt E, Binder M, Thuss-Patience P, et al
    Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic EsophagoGastric Adenocarcinoma - the randomized phase 2 INTEGA trial (AIO STO 0217).
    BMC Cancer. 2020;20:503.
    PubMed     Abstract available


    May 2020
  125. SARASWAT N, Pillay R, Everett B, George A, et al
    Knowledge, attitudes and practices of South Asian immigrants in developed countries regarding oral cancer: an integrative review.
    BMC Cancer. 2020;20:477.
    PubMed     Abstract available


  126. O'NEILL L, Guinan E, Doyle S, Connolly D, et al
    Rehabilitation strategies following oesophagogastric and Hepatopancreaticobiliary cancer (ReStOre II): a protocol for a randomized controlled trial.
    BMC Cancer. 2020;20:415.
    PubMed     Abstract available


  127. ZHOU X, Zheng Z, Chen C, Zhao B, et al
    Clinical characteristics and prognostic factors of Hurthle cell carcinoma: a population based study.
    BMC Cancer. 2020;20:407.
    PubMed     Abstract available


  128. HOESSEINI A, Dronkers EAC, Sewnaik A, Hardillo JAU, et al
    Head and neck cancer patients' preferences for individualized prognostic information: a focus group study.
    BMC Cancer. 2020;20:399.
    PubMed     Abstract available


  129. WANG BC, Xiao BY, Lin GH, Wang C, et al
    The efficacy and safety of induction chemotherapy combined with concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in nasopharyngeal carcinoma patients: a systematic review and meta-analysis.
    BMC Cancer. 2020;20:393.
    PubMed     Abstract available


  130. YANG H, Su H, Hu N, Wang C, et al
    Integrated analysis of genome-wide miRNAs and targeted gene expression in esophageal squamous cell carcinoma (ESCC) and relation to prognosis.
    BMC Cancer. 2020;20:388.
    PubMed     Abstract available


  131. HU W, Li H, Wang S
    LncRNA SNHG7 promotes the proliferation of nasopharyngeal carcinoma by miR-514a-5p/ELAVL1 axis.
    BMC Cancer. 2020;20:376.
    PubMed     Abstract available


  132. CHEN Q, Li J, Yang X, Ma J, et al
    Prdx1 promotes the loss of primary cilia in esophageal squamous cell carcinoma.
    BMC Cancer. 2020;20:372.
    PubMed     Abstract available


  133. TRAN TV, Dang KX, Pham QH, Nguyen UD, et al
    Evaluation of the expression levels of BRAF(V600E) mRNA in primary tumors of thyroid cancer using an ultrasensitive mutation assay.
    BMC Cancer. 2020;20:368.
    PubMed     Abstract available


    April 2020
  134. GOVENDER R, Smith CH, Barratt H, Gardner B, et al
    SIP SMART: a parallel group randomised feasibility trial of a tailored pre-treatment swallowing intervention package compared with usual care for patients with head and neck cancer.
    BMC Cancer. 2020;20:360.
    PubMed     Abstract available


  135. BANDO H, Kotani D, Tsushima T, Hara H, et al
    TENERGY: multicenter phase II study of Atezolizumab monotherapy following definitive Chemoradiotherapy with 5-FU plus Cisplatin in patients with unresectable locally advanced esophageal squamous cell carcinoma.
    BMC Cancer. 2020;20:336.
    PubMed     Abstract available


  136. KIM EK, Cho YA, Koh YW, Shin HA, et al
    Prognostic implications of Fibroblast growth factor receptor 1 (FGFR1) gene amplification and protein overexpression in hypopharyngeal and laryngeal squamous cell carcinoma.
    BMC Cancer. 2020;20:348.
    PubMed     Abstract available


  137. KANG HN, Kim JH, Park AY, Choi JW, et al
    Establishment and characterization of patient-derived xenografts as paraclinical models for head and neck cancer.
    BMC Cancer. 2020;20:316.
    PubMed     Abstract available


  138. CHAN MY, Lee BJ, Chang PS, Hsiao HY, et al
    The risks of ubiquinone and beta-carotene deficiency and metabolic disorders in patients with oral cancer.
    BMC Cancer. 2020;20:310.
    PubMed     Abstract available


  139. SUN HB, Xing WQ, Liu XB, Zheng Y, et al
    Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced oesophageal squamous cell carcinoma: a single-Centre, open-label, randomized, controlled, clinical trial (HCHTOG1903).
    BMC Cancer. 2020;20:303.
    PubMed     Abstract available


  140. SHEILL G, Guinan E, O'Neill L, Normand C, et al
    Preoperative exercise to improve fitness in patients undergoing complex surgery for cancer of the lung or oesophagus (PRE-HIIT): protocol for a randomized controlled trial.
    BMC Cancer. 2020;20:321.
    PubMed     Abstract available


  141. BROWN J, Stepien AJ, Willem P
    Landscape of copy number aberrations in esophageal squamous cell carcinoma from a high endemic region of South Africa.
    BMC Cancer. 2020;20:281.
    PubMed     Abstract available


  142. SUN LP, Yan LB, Liu ZZ, Zhao WJ, et al
    Dietary factors and risk of mortality among patients with esophageal cancer: a systematic review.
    BMC Cancer. 2020;20:287.
    PubMed     Abstract available


  143. WANG D, Yu S, Zhai L, Xu J, et al
    Patterns of regional lymph node failure of locally advanced hypopharyngeal squamous cell carcinoma after first-line treatment with surgery and/or intensity-modulated radiotherapy.
    BMC Cancer. 2020;20:283.
    PubMed     Abstract available


    March 2020
  144. ZHANG J, Lin H, Jiang H, Jiang H, et al
    A key genomic signature associated with lymphovascular invasion in head and neck squamous cell carcinoma.
    BMC Cancer. 2020;20:266.
    PubMed     Abstract available


  145. AL-RAJHI N, Soudy H, Ahmed SA, Elhassan T, et al
    CD3+T-lymphocyte infiltration is an independent prognostic factor for advanced nasopharyngeal carcinoma.
    BMC Cancer. 2020;20:240.
    PubMed     Abstract available


  146. SPANU A, Nuvoli S, Marongiu A, Gelo I, et al
    Neck lymph node metastasis detection in patients with differentiated thyroid carcinoma (DTC) in long-term follow-up: a (131)I-SPECT/CT study.
    BMC Cancer. 2020;20:239.
    PubMed     Abstract available


  147. KAWAUCHI K, Furuya S, Hirata K, Katoh C, et al
    A convolutional neural network-based system to classify patients using FDG PET/CT examinations.
    BMC Cancer. 2020;20:227.
    PubMed     Abstract available


  148. XIONG Y, Neskey DM, Horton JD, Paulos CM, et al
    Immunological effects of nivolumab immunotherapy in patients with oral cavity squamous cell carcinoma.
    BMC Cancer. 2020;20:229.
    PubMed     Abstract available


  149. SRISUTTEE R, Arayataweegool A, Mahattanasakul P, Tangjaturonrasme N, et al
    Evaluation of NID2 promoter methylation for screening of Oral squamous cell carcinoma.
    BMC Cancer. 2020;20:218.
    PubMed     Abstract available


  150. WU D, Hu S, Hou Y, He Y, et al
    Identification of potential novel biomarkers to differentiate malignant thyroid nodules with cytological indeterminate.
    BMC Cancer. 2020;20:199.
    PubMed     Abstract available


  151. MENG K, Tey J, Ho FCH, Asim H, et al
    Utility of magnetic resonance imaging in determining treatment response and local recurrence in nasopharyngeal carcinoma treated curatively.
    BMC Cancer. 2020;20:193.
    PubMed     Abstract available


  152. ZHANG X, Eyck BM, Yang Y, Liu J, et al
    Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma (preSINO trial): a prospective multicenter diagnostic cohort study.
    BMC Cancer. 2020;20:194.
    PubMed     Abstract available


  153. ZHANG Z, Huang J, Wang G, Jin F, et al
    Serum miRNAs, a potential prognosis marker of loco-regionally advanced nasopharyngeal carcinoma patients treated with CCRT.
    BMC Cancer. 2020;20:183.
    PubMed     Abstract available


  154. SHIRASU H, Yokota T, Hamauchi S, Onozawa Y, et al
    Risk factors for aspiration pneumonia during concurrent chemoradiotherapy or bio-radiotherapy for head and neck cancer.
    BMC Cancer. 2020;20:182.
    PubMed     Abstract available


  155. LIU Y, Wang Y, Zhao K, Li D, et al
    Lymph node metastasis in young and middle-aged papillary thyroid carcinoma patients: a SEER-based cohort study.
    BMC Cancer. 2020;20:181.
    PubMed     Abstract available


  156. LIU D, Wang Y, Zhao Y, Gu X, et al
    LncRNA SNHG5 promotes nasopharyngeal carcinoma progression by regulating miR-1179/HMGB3 axis.
    BMC Cancer. 2020;20:178.
    PubMed     Abstract available


  157. YANG J, Lu Z, Li L, Li Y, et al
    Relationship of lymphovascular invasion with lymph node metastasis and prognosis in superficial esophageal carcinoma: systematic review and meta-analysis.
    BMC Cancer. 2020;20:176.
    PubMed     Abstract available


    February 2020
  158. FEHR M, Hawle H, Hayoz S, Thuss-Patience P, et al
    High thromboembolic event rate in patients with locally advanced oesophageal cancer during neoadjuvant therapy. An exploratory analysis of the prospective, randomised intergroup phase III trial SAKK 75/08.
    BMC Cancer. 2020;20:166.
    PubMed     Abstract available


  159. UEKI S, Fujishima F, Kumagai T, Ishida H, et al
    GR, Sgk1, and NDRG1 in esophageal squamous cell carcinoma: their correlation with therapeutic outcome of neoadjuvant chemotherapy.
    BMC Cancer. 2020;20:161.
    PubMed     Abstract available


  160. BAO X, Liu F, Lin J, Chen Q, et al
    Nutritional assessment and prognosis of oral cancer patients: a large-scale prospective study.
    BMC Cancer. 2020;20:146.
    PubMed     Abstract available


  161. NI W, Yang J, Deng W, Xiao Z, et al
    Patterns of recurrence after surgery and efficacy of salvage therapy after recurrence in patients with thoracic esophageal squamous cell carcinoma.
    BMC Cancer. 2020;20:144.
    PubMed     Abstract available


  162. KINGMA BF, Eshuis WJ, de Groot EM, Feenstra ML, et al
    Paravertebral catheter versus EPidural analgesia in Minimally invasive Esophageal resectioN: a randomized controlled multicenter trial (PEPMEN trial).
    BMC Cancer. 2020;20:142.
    PubMed     Abstract available


  163. NI W, Yu S, Zhang W, Xiao Z, et al
    A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma.
    BMC Cancer. 2020;20:130.
    PubMed     Abstract available


  164. NICHOLS AC, Lang P, Prisman E, Berthelet E, et al
    Treatment de-escalation for HPV-associated oropharyngeal squamous cell carcinoma with radiotherapy vs. trans-oral surgery (ORATOR2): study protocol for a randomized phase II trial.
    BMC Cancer. 2020;20:125.
    PubMed     Abstract available


  165. ABU-HUMAIDAN AHA, Ekblad L, Wennerberg J, Sorensen OE, et al
    EGFR modulates complement activation in head and neck squamous cell carcinoma.
    BMC Cancer. 2020;20:121.
    PubMed     Abstract available


  166. YOO MH, Kim HJ, Choi IH, Park S, et al
    Shear wave elasticity by tracing total nodule showed high reproducibility and concordance with fibrosis in thyroid cancer.
    BMC Cancer. 2020;20:118.
    PubMed     Abstract available


  167. LIU D, Jian X, Xu P, Zhu R, et al
    Linc01234 promotes cell proliferation and metastasis in oral squamous cell carcinoma via miR-433/PAK4 axis.
    BMC Cancer. 2020;20:107.
    PubMed     Abstract available


  168. LIU SL, Sun XS, Xie HJ, Chen QY, et al
    Comparing three induction chemotherapy regimens for patients with locoregionally advanced nasopharyngeal carcinoma based on TNM stage and plasma Epstein-Barr virus DNA level.
    BMC Cancer. 2020;20:89.
    PubMed     Abstract available


    January 2020
  169. WANG C, Wei H, Li Y
    Comparison of fully-covered vs partially covered self-expanding metallic stents for palliative treatment of inoperable esophageal malignancy: a systematic review and meta-analysis.
    BMC Cancer. 2020;20:73.
    PubMed     Abstract available


  170. SU HA, Hsiao SW, Hsu YC, Wang LY, et al
    Superiority of NBI endoscopy to PET/CT scan in detecting esophageal cancer among head and neck cancer patients: a retrospective cohort analysis.
    BMC Cancer. 2020;20:69.
    PubMed     Abstract available


  171. YAMAMOTO K, Ohnishi S, Mizushima T, Kodaira J, et al
    Detection of early adenocarcinoma of the esophagogastric junction by spraying an enzyme-activatable fluorescent probe targeting Dipeptidyl peptidase-IV.
    BMC Cancer. 2020;20:64.
    PubMed     Abstract available


  172. JIANG Y, Zhang J, Zhao J, Li Z, et al
    Correction to: TOPK promotes metastasis of esophageal squamous cell carcinoma by activating the Src/GSK3beta/STAT3 signaling pathway via gamma-catenin.
    BMC Cancer. 2020;20:43.
    PubMed     Abstract available


  173. GU B, Zhang J, Ma G, Song S, et al
    Establishment and validation of a nomogram with intratumoral heterogeneity derived from (18)F-FDG PET/CT for predicting individual conditional risk of 5-year recurrence before initial treatment of nasopharyngeal carcinoma.
    BMC Cancer. 2020;20:37.
    PubMed     Abstract available


  174. CHEN M, Liu X, Han C, Wang X, et al
    Does chemoradiotherapy benefit elderly patients with esophageal squamous cell cancer? A propensity-score matched analysis on multicenter data (3JECROG R-03A).
    BMC Cancer. 2020;20:36.
    PubMed     Abstract available


  175. YUAN S, Lin LS, Gan RH, Huang L, et al
    Elevated matrix metalloproteinase 7 expression promotes the proliferation, motility and metastasis of tongue squamous cell carcinoma.
    BMC Cancer. 2020;20:33.
    PubMed     Abstract available


  176. SAKANAKA K, Fujii K, Mizowaki T
    Adaptive radiotherapy in locally advanced esophageal cancer with atelectasis: a case report.
    BMC Cancer. 2020;20:21.
    PubMed     Abstract available


  177. SCHALLENBERG S, Bork J, Essakly A, Alakus H, et al
    Loss of the SWI/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinoma.
    BMC Cancer. 2020;20:12.
    PubMed     Abstract available


  178. MELO-HANCHUK TD, Martins MB, Cunha LL, Soares FA, et al
    Expression of the NEK family in normal and cancer tissue: an immunohistochemical study.
    BMC Cancer. 2020;20:23.
    PubMed     Abstract available


    December 2019
  179. LU Y, Chen D, Liang J, Gao J, et al
    Administration of nimotuzumab combined with cisplatin plus 5-fluorouracil as induction therapy improves treatment response and tolerance in patients with locally advanced nasopharyngeal carcinoma receiving concurrent radiochemotherapy: a multicenter r
    BMC Cancer. 2019;19:1262.
    PubMed     Abstract available


  180. JIANG Y, Zhang J, Zhao J, Li Z, et al
    TOPK promotes metastasis of esophageal squamous cell carcinoma by activating the Src/GSK3beta/STAT3 signaling pathway via gamma-catenin.
    BMC Cancer. 2019;19:1264.
    PubMed     Abstract available


  181. FANG CW, Wang JS, Wu TT, Lin JT, et al
    Occurrence of paratesticular ganglioneuroma 18 years after concurrent adrenal ganglioneuroma and papillary thyroid carcinoma - a case report.
    BMC Cancer. 2019;19:1265.
    PubMed     Abstract available


  182. SUH HY, Choi H, Paeng JC, Cheon GJ, et al
    Comprehensive gene expression analysis for exploring the association between glucose metabolism and differentiation of thyroid cancer.
    BMC Cancer. 2019;19:1260.
    PubMed     Abstract available


  183. ZAPATA I, Alvarez M, Hidalgo R, Pajares B, et al
    Causes of death in patients with locally advanced head and neck cancer treated with radiotherapy and systemic therapy.
    BMC Cancer. 2019;19:1241.
    PubMed     Abstract available


  184. XUE KS, Tang L, Sun G, Wang S, et al
    Mycotoxin exposure is associated with increased risk of esophageal squamous cell carcinoma in Huaian area, China.
    BMC Cancer. 2019;19:1218.
    PubMed     Abstract available


  185. FLEEMAN N, Houten R, Chaplin M, Beale S, et al
    A systematic review of lenvatinib and sorafenib for treating progressive, locally advanced or metastatic, differentiated thyroid cancer after treatment with radioactive iodine.
    BMC Cancer. 2019;19:1209.
    PubMed     Abstract available


  186. SUNPAWERAVONG S, Bunbanjerdsuk S, Pongrujikorn T, Naktang C, et al
    Clonal relationship of synchronous head and neck cancer and esophageal cancer assessed by single nucleotide polymorphism-based loss of heterozygosity analysis.
    BMC Cancer. 2019;19:1174.
    PubMed     Abstract available


    November 2019
  187. LIU Z, Shi H, Chen L
    Prognostic role of pre-treatment C-reactive protein/albumin ratio in esophageal cancer: a meta-analysis.
    BMC Cancer. 2019;19:1161.
    PubMed     Abstract available


  188. CORDES M, Gotz TI, Horstrup K, Kuwert T, et al
    Growth rates of malignant and benign thyroid nodules in an ultrasound follow-up study: a retrospective cohort study.
    BMC Cancer. 2019;19:1139.
    PubMed     Abstract available


  189. ZHI-QIANG W, Qi M, Ji-Bin L, Rui Y, et al
    The long-term survival of patients with III-IVb stage nasopharyngeal carcinoma treated with IMRT with or without Nimotuzumab: a propensity score-matched analysis.
    BMC Cancer. 2019;19:1122.
    PubMed     Abstract available


  190. DE VEIJ MESTDAGH PD, Schreuder WH, Vogel WV, Donswijk ML, et al
    Mapping of sentinel lymph node drainage using SPECT/CT to tailor elective nodal irradiation in head and neck cancer patients (SUSPECT-2): a single-center prospective trial.
    BMC Cancer. 2019;19:1110.
    PubMed     Abstract available


  191. AIMJONGJUN S, Mahmud Z, Jiramongkol Y, Alasiri G, et al
    Lapatinib sensitivity in nasopharyngeal carcinoma is modulated by SIRT2-mediated FOXO3 deacetylation.
    BMC Cancer. 2019;19:1106.
    PubMed     Abstract available


  192. XUE L, Yan H, Chen Y, Zhang Q, et al
    EZH2 upregulation by ERalpha induces proliferation and migration of papillary thyroid carcinoma.
    BMC Cancer. 2019;19:1094.
    PubMed     Abstract available


  193. LIN YW, Huang ST, Wu JC, Chu TH, et al
    Novel HDGF/HIF-1alpha/VEGF axis in oral cancer impacts disease prognosis.
    BMC Cancer. 2019;19:1083.
    PubMed     Abstract available


  194. VAN DER VORST MJDL, Neefjes ECW, Toffoli EC, Oosterling-Jansen JEW, et al
    Incidence and risk factors for acute kidney injury in head and neck cancer patients treated with concurrent chemoradiation with high-dose cisplatin.
    BMC Cancer. 2019;19:1066.
    PubMed     Abstract available


  195. QIU ML, Lin JB, Li X, Luo RG, et al
    Current state of esophageal cancer surgery in China: a national database analysis.
    BMC Cancer. 2019;19:1064.
    PubMed     Abstract available


  196. NOPMANEEPAISARN T, Tangjaturonrasme N, Rawangban W, Vinayanuwattikun C, et al
    Low prevalence of p16-positive HPV-related head-neck cancers in Thailand: tertiary referral center experience.
    BMC Cancer. 2019;19:1050.
    PubMed     Abstract available


  197. YADAV S, Bhagat SD, Gupta A, Samaiya A, et al
    Dietary-phytochemical mediated reversion of cancer-specific splicing inhibits Warburg effect in head and neck cancer.
    BMC Cancer. 2019;19:1031.
    PubMed     Abstract available


    October 2019
  198. CAO Y, Chan KI, Xiao G, Chen Y, et al
    Expression and clinical significance of PD-L1 and BRAF expression in nasopharyngeal carcinoma.
    BMC Cancer. 2019;19:1022.
    PubMed     Abstract available


  199. LIU P, McMenamin UC, Spence AD, Johnston BT, et al
    Furosemide use and survival in patients with esophageal or gastric cancer: a population-based cohort study.
    BMC Cancer. 2019;19:1017.
    PubMed     Abstract available


  200. TITOV SE, Ivanov MK, Demenkov PS, Katanyan GA, et al
    Combined quantitation of HMGA2 mRNA, microRNAs, and mitochondrial-DNA content enables the identification and typing of thyroid tumors in fine-needle aspiration smears.
    BMC Cancer. 2019;19:1010.
    PubMed     Abstract available


  201. LI KJ, Xia XF, Su M, Zhang H, et al
    Predictive value of lymphocyte-to-monocyte ratio (LMR) and neutrophil-to-lymphocyte ratio (NLR) in patients with oesophageal cancer undergoing concurrent chemoradiotherapy.
    BMC Cancer. 2019;19:1004.
    PubMed     Abstract available


  202. LU Y, Ma L, Qin J, Wang Z, et al
    The value of GRASP on DCE-MRI for assessing response to neoadjuvant chemotherapy in patients with esophageal cancer.
    BMC Cancer. 2019;19:999.
    PubMed     Abstract available


  203. VERDONCK-DE LEEUW IM, Jansen F, Brakenhoff RH, Langendijk JA, et al
    Correction to: Advancing interdisciplinary research in head and neck cancer through a multicenter longitudinal prospective cohort study: the NETherlands QUality of life and BIomedical Cohort (NET-QUBIC) data warehouse and biobank.
    BMC Cancer. 2019;19:982.
    PubMed     Abstract available


    September 2019
  204. YU J, Ouyang W, Li C, Shen J, et al
    Mapping patterns of metastatic lymph nodes for postoperative radiotherapy in thoracic esophageal squamous cell carcinoma: a recommendation for clinical target volume definition.
    BMC Cancer. 2019;19:927.
    PubMed     Abstract available


  205. HOU Y, Deng W, Deng G, Hu L, et al
    Gingival metastasis from primary hepatocellular carcinoma: a case report and literature review of 30 cases.
    BMC Cancer. 2019;19:925.
    PubMed     Abstract available


  206. SUN XS, Liang YJ, Liu SL, Chen QY, et al
    Maximal standard uptake values of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography compared with Epstein-Barr virus DNA as prognostic indicators in de novo metastatic nasopharyngeal carcinoma patients.
    BMC Cancer. 2019;19:908.
    PubMed     Abstract available


  207. DE HAAN R, van Werkhoven E, van den Heuvel MM, Peulen HMU, et al
    Study protocols of three parallel phase 1 trials combining radical radiotherapy with the PARP inhibitor olaparib.
    BMC Cancer. 2019;19:901.
    PubMed     Abstract available


  208. YEO ST, Bray N, Haboubi H, Hoare Z, et al
    Endoscopic ultrasound staging in patients with gastro-oesophageal cancers: a systematic review of economic evidence.
    BMC Cancer. 2019;19:900.
    PubMed     Abstract available


  209. XU F, Zhang S, Liu Z, Gu J, et al
    TEX9 and eIF3b functionally synergize to promote the progression of esophageal squamous cell carcinoma.
    BMC Cancer. 2019;19:875.
    PubMed     Abstract available


    August 2019
  210. TAO Y, Shi L, Ge L, Yuan T, et al
    Sinonasal desmoplastic small round cell tumor: a case report and review of the literature.
    BMC Cancer. 2019;19:868.
    PubMed     Abstract available


  211. TSOU YA, Chang WD, Lu JJ, Wu TF, et al
    The effect of metformin use on hypopharyngeal squamous cell carcinoma in diabetes mellitus patients.
    BMC Cancer. 2019;19:862.
    PubMed     Abstract available


  212. WU L, Zheng K, Yan C, Pan X, et al
    Genome-wide study of salivary microRNAs as potential noninvasive biomarkers for detection of nasopharyngeal carcinoma.
    BMC Cancer. 2019;19:843.
    PubMed     Abstract available


  213. SHENG X, Li Y, Li Y, Liu W, et al
    PLOD2 contributes to drug resistance in laryngeal cancer by promoting cancer stem cell-like characteristics.
    BMC Cancer. 2019;19:840.
    PubMed     Abstract available


  214. QADIR F, Lalli A, Dar HH, Hwang S, et al
    Clinical correlation of opposing molecular signatures in head and neck squamous cell carcinoma.
    BMC Cancer. 2019;19:830.
    PubMed     Abstract available


  215. GOMEZ-ACEVEDO H, Patterson JD, Sardar S, Gokden M, et al
    SMARC-B1 deficient sinonasal carcinoma metastasis to the brain with next generation sequencing data: a case report of perineural invasion progressing to leptomeningeal invasion.
    BMC Cancer. 2019;19:827.
    PubMed     Abstract available


  216. MENG P, Wei J, Geng Y, Chen S, et al
    Targeted sequencing of circulating cell-free DNA in stage II-III resectable oesophageal squamous cell carcinoma patients.
    BMC Cancer. 2019;19:818.
    PubMed     Abstract available


  217. SASSENBERG M, Droop J, Schulz WA, Dietrich D, et al
    Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma.
    BMC Cancer. 2019;19:806.
    PubMed     Abstract available


  218. BIBBY BAS, Miranda CS, Reynolds JV, Cawthorne CJ, et al
    Silencing microRNA-330-5p increases MMP1 expression and promotes an invasive phenotype in oesophageal adenocarcinoma.
    BMC Cancer. 2019;19:784.
    PubMed     Abstract available


  219. ZHOU RS, Zhang EX, Sun QF, Ye ZJ, et al
    Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue.
    BMC Cancer. 2019;19:779.
    PubMed     Abstract available


  220. DU W, Fang Q, Wu Y, Wu J, et al
    Oncologic outcome of marginal mandibulectomy in squamous cell carcinoma of the lower gingiva.
    BMC Cancer. 2019;19:775.
    PubMed     Abstract available


  221. VERDONCK-DE LEEUW IM, Jansen F, Brakenhoff RH, Langendijk JA, et al
    Advancing interdisciplinary research in head and neck cancer through a multicenter longitudinal prospective cohort study: the NETherlands QUality of life and BIomedical Cohort (NET-QUBIC) data warehouse and biobank.
    BMC Cancer. 2019;19:765.
    PubMed     Abstract available


    July 2019
  222. FANG Q, Wu J, Liu F
    Oncologic outcome and potential prognostic factors in primary squamous cell carcinoma of the parotid gland.
    BMC Cancer. 2019;19:752.
    PubMed     Abstract available


  223. GAO XL, Zheng M, Wang HF, Dai LL, et al
    NR2F1 contributes to cancer cell dormancy, invasion and metastasis of salivary adenoid cystic carcinoma by activating CXCL12/CXCR4 pathway.
    BMC Cancer. 2019;19:743.
    PubMed     Abstract available


  224. FU X, Li T, Dai Y, Li J, et al
    Preoperative systemic inflammation score (SIS) is superior to neutrophil to lymphocyte ratio (NLR) as a predicting indicator in patients with esophageal squamous cell carcinoma.
    BMC Cancer. 2019;19:721.
    PubMed     Abstract available


  225. HAN WH, Eom BW, Yoon HM, Reim D, et al
    The optimal extent of lymph node dissection in gastroesophageal junctional cancer: retrospective case control study.
    BMC Cancer. 2019;19:719.
    PubMed     Abstract available


  226. WU K, Wei J, Liu Z, Yu B, et al
    Can pattern and depth of invasion predict lymph node relapse and prognosis in tongue squamous cell carcinoma.
    BMC Cancer. 2019;19:714.
    PubMed     Abstract available


  227. YU X, Chen YA, Conejo-Garcia JR, Chung CH, et al
    Estimation of immune cell content in tumor using single-cell RNA-seq reference data.
    BMC Cancer. 2019;19:715.
    PubMed     Abstract available


  228. REZAEI M, Khamaneh AM, Zarghami N, Vosoughi A, et al
    Evaluating pre- and post-operation plasma miRNAs of papillary thyroid carcinoma (PTC) patients in comparison to benign nodules.
    BMC Cancer. 2019;19:690.
    PubMed     Abstract available


  229. GUINAN EM, Bennett AE, Doyle SL, O'Neill L, et al
    Measuring the impact of oesophagectomy on physical functioning and physical activity participation: a prospective study.
    BMC Cancer. 2019;19:682.
    PubMed     Abstract available


  230. VAN GYSEN K, Stevens M, Guo L, Jayamanne D, et al
    Validation of the 8(th) edition UICC/AJCC TNM staging system for HPV associated oropharyngeal cancer patients managed with contemporary chemo-radiotherapy.
    BMC Cancer. 2019;19:674.
    PubMed     Abstract available


  231. HAGENS ERC, van Berge Henegouwen MI, van Sandick JW, Cuesta MA, et al
    Distribution of lymph node metastases in esophageal carcinoma [TIGER study]: study protocol of a multinational observational study.
    BMC Cancer. 2019;19:662.
    PubMed     Abstract available


  232. TANG X, Sun Y, Wan G, Sun J, et al
    Knockdown of YAP inhibits growth in Hep-2 laryngeal cancer cells via epithelial-mesenchymal transition and the Wnt/beta-catenin pathway.
    BMC Cancer. 2019;19:654.
    PubMed     Abstract available


  233. CHEN Y, Yang Z, Wang Y, Wang J, et al
    Karyotyping of circulating tumor cells for predicting chemotherapeutic sensitivity and efficacy in patients with esophageal cancer.
    BMC Cancer. 2019;19:651.
    PubMed     Abstract available


  234. BECK ACC, Passchier E, Retel VP, Stuiver MM, et al
    Study protocol of a prospective multicenter study comparing (cost-)effectiveness of a tailored interdisciplinary head and neck rehabilitation program to usual supportive care for patients treated with concomitant chemo- or bioradiotherapy.
    BMC Cancer. 2019;19:655.
    PubMed     Abstract available


    June 2019
  235. TORTOLERO-LUNA G, Torres-Cintron CR, Alvarado-Ortiz M, Ortiz-Ortiz KJ, et al
    Incidence of thyroid cancer in Puerto Rico and the US by racial/ethnic group, 2011-2015.
    BMC Cancer. 2019;19:637.
    PubMed     Abstract available


  236. RUUSKANEN M, Leivo I, Minn H, Vahlberg T, et al
    Expression of toll-like receptors in non-endemic nasopharyngeal carcinoma.
    BMC Cancer. 2019;19:624.
    PubMed     Abstract available


  237. LIU C, Xiao C, Chen J, Li X, et al
    Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients.
    BMC Cancer. 2019;19:622.
    PubMed     Abstract available


  238. YANG Y, Zhang X, Li B, Li Z, et al
    Robot-assisted esophagectomy (RAE) versus conventional minimally invasive esophagectomy (MIE) for resectable esophageal squamous cell carcinoma: protocol for a multicenter prospective randomized controlled trial (RAMIE trial, robot-assisted minimally
    BMC Cancer. 2019;19:608.
    PubMed     Abstract available


  239. ZENG B, Zhang X, Zhao J, Wei Z, et al
    The role of DNMT1/hsa-miR-124-3p/BCAT1 pathway in regulating growth and invasion of esophageal squamous cell carcinoma.
    BMC Cancer. 2019;19:609.
    PubMed     Abstract available


  240. ZHOU Y, Sinha S, Schwartz JL, Adami GR, et al
    A subtype of oral, laryngeal, esophageal, and lung, squamous cell carcinoma with high levels of TrkB-T1 neurotrophin receptor mRNA.
    BMC Cancer. 2019;19:607.
    PubMed     Abstract available


  241. LIU X, Jin J, Cai H, Huang H, et al
    Study protocol of a randomized phase III trial of comparing preoperative chemoradiation with preoperative chemotherapy in patients with locally advanced gastric cancer or esophagogastric junction adenocarcinoma: PREACT.
    BMC Cancer. 2019;19:606.
    PubMed     Abstract available


  242. XU M, Wang X, Pan Y, Zhao X, et al
    Blocking podoplanin suppresses growth and pulmonary metastasis of human malignant melanoma.
    BMC Cancer. 2019;19:599.
    PubMed     Abstract available


  243. QIAN Z, Wei B, Zhou Y, Wang Q, et al
    PRAF2 overexpression predicts poor prognosis and promotes tumorigenesis in esophageal squamous cell carcinoma.
    BMC Cancer. 2019;19:585.
    PubMed     Abstract available


  244. BROWN SR, Hall A, Buckley HL, Flanagan L, et al
    Investigating the potential clinical benefit of Selumetinib in resensitising advanced iodine refractory differentiated thyroid cancer to radioiodine therapy (SEL-I-METRY): protocol for a multicentre UK single arm phase II trial.
    BMC Cancer. 2019;19:582.
    PubMed     Abstract available


  245. LEKOANE KMB, Kuupiel D, Mashamba-Thompson TP, Ginindza TG, et al
    Evidence on the prevalence, incidence, mortality and trends of human papilloma virus-associated cancers in sub-Saharan Africa: systematic scoping review.
    BMC Cancer. 2019;19:563.
    PubMed     Abstract available


  246. LIU F, Luo T, Jin T, Zhang J, et al
    Advantages of using reduced-volume intensity modulated radiation therapy for the treatment of nasopharyngeal carcinoma: a retrospective paired study.
    BMC Cancer. 2019;19:554.
    PubMed     Abstract available


  247. YANG WH, Yang YH, Chen PC, Wang TC, et al
    Intracranial aneurysms formation after radiotherapy for head and neck cancer: a 10-year nationwide follow-up study.
    BMC Cancer. 2019;19:537.
    PubMed     Abstract available


    May 2019
  248. YANG Y, Huang X, Zhou L, Deng T, et al
    Clinical use of tumor biomarkers in prediction for prognosis and chemotherapeutic effect in esophageal squamous cell carcinoma.
    BMC Cancer. 2019;19:526.
    PubMed     Abstract available


  249. SCHIFFMANN LM, Gobel H, Loser H, Schorn F, et al
    Elevated X-linked inhibitor of apoptosis protein (XIAP) expression uncovers detrimental prognosis in subgroups of neoadjuvant treated and T-cell rich esophageal adenocarcinoma.
    BMC Cancer. 2019;19:531.
    PubMed     Abstract available


  250. DI L, Fu KI, Wu X, Liu X, et al
    Endoscopic features and associated histology of an basaloid squamous cell carcinoma of the esophagus at the very early stage.
    BMC Cancer. 2019;19:513.
    PubMed     Abstract available


  251. JIANG F, Yu W, Zeng F, Cheng G, et al
    PD-1 high expression predicts lower local disease control in stage IV M0 nasopharyngeal carcinoma.
    BMC Cancer. 2019;19:503.
    PubMed     Abstract available


  252. WANG Q, Wu Z, Zhan T, Fang S, et al
    Comparison of minimally invasive Ivor Lewis esophagectomy and left transthoracic esophagectomy in esophageal squamous cell carcinoma patients: a propensity score-matched analysis.
    BMC Cancer. 2019;19:500.
    PubMed     Abstract available


  253. WAGNER AD, Grabsch HI, Mauer M, Marreaud S, et al
    EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction
    BMC Cancer. 2019;19:494.
    PubMed     Abstract available


  254. LI C, Wang X, Wang X, Han C, et al
    Correction to: A multicenter phase III study comparing Simultaneous Integrated Boost (SIB) radiotherapy concurrent and consolidated with S-1 versus SIB alone in elderly patients with esophageal and esophagogastric cancer - the 3JECROG P-01 study proto
    BMC Cancer. 2019;19:492.
    PubMed     Abstract available


  255. YANG Z, Liao J, Carter-Cooper BA, Lapidus RG, et al
    Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ETS-1 signaling pathway.
    BMC Cancer. 2019;19:485.
    PubMed     Abstract available


  256. WANG K, Dong J, He S, Wang X, et al
    Comparison of weekly and triweekly cisplatin regimens during concurrent chemoradiotherapy for nasopharyngeal carcinoma.
    BMC Cancer. 2019;19:482.
    PubMed     Abstract available


  257. FANG Q, Wu J, Du W, Zhang X, et al
    Predictors of distant metastasis in parotid acinic cell carcinoma.
    BMC Cancer. 2019;19:475.
    PubMed     Abstract available


  258. HUANG TX, Lu N, Lian SS, Li H, et al
    The primary lesion apparent diffusion coefficient is a prognostic factor for locoregionally advanced nasopharyngeal carcinoma: a retrospective study.
    BMC Cancer. 2019;19:470.
    PubMed     Abstract available


  259. BAJ A, Fusco N, Bolzoni A, Carioli D, et al
    A novel integrated platform for the identification of surgical margins in oral squamous cell carcinoma: results from a prospective single-institution series.
    BMC Cancer. 2019;19:467.
    PubMed     Abstract available


  260. LIN CL, Wu SY, Huang WT, Feng YH, et al
    Subsequent thyroid disorders associated with treatment strategy in head and neck cancer patients: a nationwide cohort study.
    BMC Cancer. 2019;19:461.
    PubMed     Abstract available


  261. GAO Y, Yuan L, Pan B, Wang L, et al
    Resilience and associated factors among Chinese patients diagnosed with oral cancer.
    BMC Cancer. 2019;19:447.
    PubMed     Abstract available


  262. LIAO LJ, Hsu WL, Lo WC, Cheng PW, et al
    Health-related quality of life and utility in head and neck cancer survivors.
    BMC Cancer. 2019;19:425.
    PubMed     Abstract available


  263. NIU X, Fang Q, Liu F
    Role of intraparotid node metastasis in mucoepidermoid carcinoma of the parotid gland.
    BMC Cancer. 2019;19:417.
    PubMed     Abstract available


    April 2019
  264. LI C, Wang X, Wang X, Han C, et al
    A multicenter phase III study comparing Simultaneous Integrated Boost (SIB) radiotherapy concurrent and consolidated with S-1 versus SIB alone in elderly patients with esophageal and esophagogastric cancer - the 3JECROG P-01 study protocol.
    BMC Cancer. 2019;19:397.
    PubMed     Abstract available


  265. SU W, Wang Y, Wang F, Sun S, et al
    Hsa_circ_0005379 regulates malignant behavior of oral squamous cell carcinoma through the EGFR pathway.
    BMC Cancer. 2019;19:400.
    PubMed     Abstract available


  266. LI JY, Huang WX, Zhou X, Chen J, et al
    Numb inhibits epithelial-mesenchymal transition via RBP-Jkappa-dependent Notch1/PTEN/FAK signaling pathway in tongue cancer.
    BMC Cancer. 2019;19:391.
    PubMed     Abstract available


  267. RODRIGUES-JUNIOR DM, Tan SS, de Souza Viana L, Carvalho AL, et al
    A preliminary investigation of circulating extracellular vesicles and biomarker discovery associated with treatment response in head and neck squamous cell carcinoma.
    BMC Cancer. 2019;19:373.
    PubMed     Abstract available


  268. SUR S, Nakanishi H, Steele R, Ray RB, et al
    Depletion of PCAT-1 in head and neck cancer cells inhibits tumor growth and induces apoptosis by modulating c-Myc-AKT1-p38 MAPK signalling pathways.
    BMC Cancer. 2019;19:354.
    PubMed     Abstract available


  269. FU JY, Wu CX, Shen SK, Zheng Y, et al
    Salivary gland carcinoma in Shanghai (2003-2012): an epidemiological study of incidence, site and pathology.
    BMC Cancer. 2019;19:350.
    PubMed     Abstract available


  270. GAO G, Wang J, Kasperbauer JL, Tombers NM, et al
    Whole genome sequencing reveals complexity in both HPV sequences present and HPV integrations in HPV-positive oropharyngeal squamous cell carcinomas.
    BMC Cancer. 2019;19:352.
    PubMed     Abstract available


  271. BEUKHOF CM, Brabander T, van Nederveen FH, van Velthuysen MF, et al
    Peptide receptor radionuclide therapy in patients with medullary thyroid carcinoma: predictors and pitfalls.
    BMC Cancer. 2019;19:325.
    PubMed     Abstract available


  272. KOIZUMI W, Kitago M, Shinoda M, Yagi H, et al
    Successful resection of pancreatic metastasis from oesophageal squamous cell carcinoma: a case report and review of the literature.
    BMC Cancer. 2019;19:320.
    PubMed     Abstract available


  273. SONG B, Li R, Zuo Z, Tan J, et al
    LncRNA ENST00000539653 acts as an oncogenic factor via MAPK signalling in papillary thyroid cancer.
    BMC Cancer. 2019;19:297.
    PubMed     Abstract available


  274. SALAZAR-VEGA J, Ortiz-Prado E, Solis-Pazmino P, Gomez-Barreno L, et al
    Thyroid Cancer in Ecuador, a 16 years population-based analysis (2001-2016).
    BMC Cancer. 2019;19:294.
    PubMed     Abstract available


    March 2019
  275. CHEN YF, Liu CJ, Lin LH, Chou CH, et al
    Establishing of mouse oral carcinoma cell lines derived from transgenic mice and their use as syngeneic tumorigenesis models.
    BMC Cancer. 2019;19:281.
    PubMed     Abstract available


  276. CHE J, Wang Y, Zhang X, Chen J, et al
    Comparative efficacy of six therapies for Hypopharyngeal and laryngeal neoplasms: a network meta-analysis.
    BMC Cancer. 2019;19:282.
    PubMed     Abstract available


  277. HARLE A, Guillet J, Thomas J, Demange J, et al
    HPV insertional pattern as a personalized tumor marker for the optimized tumor diagnosis and follow-up of patients with HPV-associated carcinomas: a case report.
    BMC Cancer. 2019;19:277.
    PubMed     Abstract available


  278. FORSLUND O, Sugiyama N, Wu C, Ravi N, et al
    A novel human in vitro papillomavirus type 16 positive tonsil cancer cell line with high sensitivity to radiation and cisplatin.
    BMC Cancer. 2019;19:265.
    PubMed     Abstract available


  279. RILEY A, Green V, Cheah R, McKenzie G, et al
    A novel microfluidic device capable of maintaining functional thyroid carcinoma specimens ex vivo provides a new drug screening platform.
    BMC Cancer. 2019;19:259.
    PubMed     Abstract available


  280. SHEN Z, Liao X, Shao Z, Feng M, et al
    Short-term stimulation with histone deacetylase inhibitor trichostatin a induces epithelial-mesenchymal transition in nasopharyngeal carcinoma cells without increasing cell invasion ability.
    BMC Cancer. 2019;19:262.
    PubMed     Abstract available


  281. WANG Y, Jiang Z, Xu C, Wang H, et al
    Increased MET gene copy number negatively affects the survival of esophageal squamous cell carcinoma patients.
    BMC Cancer. 2019;19:240.
    PubMed     Abstract available


  282. TESHIMA M, Tokita K, Ryo E, Matsumoto F, et al
    Clinical impact of a cytological screening system using cyclin D1 immunostaining and genomic analysis for the diagnosis of thyroid nodules.
    BMC Cancer. 2019;19:245.
    PubMed     Abstract available


  283. MEINDL-BEINKER NM, Betge J, Gutting T, Burgermeister E, et al
    A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA).
    BMC Cancer. 2019;19:231.
    PubMed     Abstract available


  284. HAYASHI Y, Iijima H, Isohashi F, Tsujii Y, et al
    The heart's exposure to radiation increases the risk of cardiac toxicity after chemoradiotherapy for superficial esophageal cancer: a retrospective cohort study.
    BMC Cancer. 2019;19:195.
    PubMed     Abstract available


  285. MEHNERT JM, Varga A, Brose MS, Aggarwal RR, et al
    Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced, PD-L1-positive papillary or follicular thyroid cancer.
    BMC Cancer. 2019;19:196.
    PubMed     Abstract available


  286. HUMMEL S, Kohlmann W, Kollmeyer TM, Jenkins R, et al
    The contribution of the rs55705857 G allele to familial cancer risk as estimated in the Utah population database.
    BMC Cancer. 2019;19:190.
    PubMed     Abstract available


    February 2019
  287. A AL HAMAD M, Albisher HM, Al Saeed WR, Almumtin AT, et al
    BRAF gene mutations in synchronous papillary thyroid carcinoma and Langerhans cell histiocytosis co-existing in the thyroid gland: a case report and literature review.
    BMC Cancer. 2019;19:170.
    PubMed     Abstract available


  288. SONG L, Wang Y, Weng G
    Metastasis in penile corpus cavernosum from esophageal squamous carcinoma after curative resection: a case report.
    BMC Cancer. 2019;19:162.
    PubMed     Abstract available


  289. ROT S, Kaune T, Taubert H, Greither T, et al
    Prognostic impact of mRNA levels of LGR5 transcript variants in OSCC patients.
    BMC Cancer. 2019;19:155.
    PubMed     Abstract available


  290. GUANG Y, He W, Luo Y, Zhang H, et al
    Patient satisfaction of radiofrequency ablation for symptomatic benign solid thyroid nodules: our experience for 2-year follow up.
    BMC Cancer. 2019;19:147.
    PubMed     Abstract available


    January 2019
  291. CUI Z, Zhao Y
    microRNA-342-3p targets FOXQ1 to suppress the aggressive phenotype of nasopharyngeal carcinoma cells.
    BMC Cancer. 2019;19:104.
    PubMed     Abstract available


  292. SUN XS, Liu LT, Liu SL, Guo SS, et al
    Identifying optimal candidates for local treatment of the primary tumor among patients with de novo metastatic nasopharyngeal carcinoma: a retrospective cohort study based on Epstein-Barr virus DNA level and tumor response to palliative chemotherapy.
    BMC Cancer. 2019;19:92.
    PubMed     Abstract available


  293. SIKORSKA J, Gawel D, Domek H, Rudzinska M, et al
    Podoplanin (PDPN) affects the invasiveness of thyroid carcinoma cells by inducing ezrin, radixin and moesin (E/R/M) phosphorylation in association with matrix metalloproteinases.
    BMC Cancer. 2019;19:85.
    PubMed     Abstract available


  294. YOU GR, Cheng AJ, Lee LY, Huang YC, et al
    Prognostic signature associated with radioresistance in head and neck cancer via transcriptomic and bioinformatic analyses.
    BMC Cancer. 2019;19:64.
    PubMed     Abstract available


  295. BAHIG H, Aubin F, Stagg J, Gologan O, et al
    Phase I/II trial of Durvalumab plus Tremelimumab and stereotactic body radiotherapy for metastatic head and neck carcinoma.
    BMC Cancer. 2019;19:68.
    PubMed     Abstract available


  296. YAO JJ, Zhu FT, Dong J, Liang ZB, et al
    Prognostic value of neutrophil-to-lymphocyte ratio in advanced nasopharyngeal carcinoma: a large institution-based cohort study from an endemic area.
    BMC Cancer. 2019;19:37.
    PubMed     Abstract available


  297. PLUM PS, Gebauer F, Kramer M, Alakus H, et al
    HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma.
    BMC Cancer. 2019;19:38.
    PubMed     Abstract available


  298. IWATSUBO T, Ishihara R, Morishima T, Maekawa A, et al
    Impact of age at diagnosis of head and neck cancer on incidence of metachronous cancer.
    BMC Cancer. 2019;19:3.
    PubMed     Abstract available


    December 2018
  299. LIANG YJ, Tang LQ, Sun XS, Fan YY, et al
    Symptomatic venous thromboembolism associated with peripherally inserted central catheters predicts a worse survival in nasopharyngeal carcinoma: results of a large cohort, propensity score-matched analysis.
    BMC Cancer. 2018;18:1297.
    PubMed     Abstract available


  300. LIU SL, Sun XS, Li XY, Chen QY, et al
    Liposomal paclitaxel versus docetaxel in induction chemotherapy using Taxanes, cisplatin and 5-fluorouracil for locally advanced nasopharyngeal carcinoma.
    BMC Cancer. 2018;18:1279.
    PubMed     Abstract available


  301. ZHANG J, Peng H, Li WF, Zhang Y, et al
    Individualized induction chemotherapy by pre-treatment plasma Epstein-Barr viral DNA in advanced nasopharyngeal carcinoma.
    BMC Cancer. 2018;18:1276.
    PubMed     Abstract available


  302. MAKITA Y, Kunii N, Sakurai D, Ihara F, et al
    Activated iNKT cells enhance the anti-tumor effect of antigen specific CD8 T cells on mesothelin-expressing salivary gland cancer.
    BMC Cancer. 2018;18:1254.
    PubMed     Abstract available


  303. HU YC, Tsai KW, Lee CC, Peng NJ, et al
    Which nasopharyngeal cancer patients need adaptive radiotherapy?
    BMC Cancer. 2018;18:1234.
    PubMed     Abstract available


  304. HATOYAMA K, Taniyama Y, Sakurai T, Sato C, et al
    Esophageal cancer with severe funnel chest treated by simultaneous funnel chest surgery and thoracoscopic esophagectomy: a case report.
    BMC Cancer. 2018;18:1212.
    PubMed     Abstract available


  305. SEGAOULA Z, Primot A, Lepretre F, Hedan B, et al
    Isolation and characterization of two canine melanoma cell lines: new models for comparative oncology.
    BMC Cancer. 2018;18:1219.
    PubMed     Abstract available


  306. ZARKESH M, Zadeh-Vakili A, Akbarzadeh M, Fanaei SA, et al
    The role of matrix metalloproteinase-9 as a prognostic biomarker in papillary thyroid cancer.
    BMC Cancer. 2018;18:1199.
    PubMed     Abstract available


    November 2018
  307. TALAGALA IA, Arambepola C
    Changes in quality of life following initial treatment of oesophageal carcinoma: a cohort study from Sri Lanka.
    BMC Cancer. 2018;18:1184.
    PubMed     Abstract available


  308. HUANG ZH, Ma XW, Zhang J, Li X, et al
    Cetuximab for esophageal cancer: an updated meta-analysis of randomized controlled trials.
    BMC Cancer. 2018;18:1170.
    PubMed     Abstract available


  309. KONG F, Zhou J, Du C, He X, et al
    Long-term survival and late complications of intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.
    BMC Cancer. 2018;18:1139.
    PubMed     Abstract available


  310. ZHANG J, Shi H, Jiang T, Liu Z, et al
    Circulating tumor cells with karyotyping as a novel biomarker for diagnosis and treatment of nasopharyngeal carcinoma.
    BMC Cancer. 2018;18:1133.
    PubMed     Abstract available


  311. TALAGALA IA, Nawarathne M, Arambepola C
    Novel risk factors for primary prevention of oesophageal carcinoma: a case-control study from Sri Lanka.
    BMC Cancer. 2018;18:1135.
    PubMed     Abstract available


  312. GE X, Yu J, Wang Z, Xu Y, et al
    Comparative study of dual energy CT iodine imaging and standardized concentrations before and after chemoradiotherapy for esophageal cancer.
    BMC Cancer. 2018;18:1120.
    PubMed     Abstract available


  313. GRUPP K, Hofmann B, Kutup A, Bachmann K, et al
    Reduced RBM3 expression is associated with aggressive tumor features in esophageal cancer but not significantly linked to patient outcome.
    BMC Cancer. 2018;18:1106.
    PubMed     Abstract available


  314. ZHANG L, Li Z, Liu Y, Xu S, et al
    Analysis of oncogenic activities of protein kinase D1 in head and neck squamous cell carcinoma.
    BMC Cancer. 2018;18:1107.
    PubMed     Abstract available


  315. CHUA KLM, Yeo ELL, Shihabudeen WA, Tan SH, et al
    Intra-patient and inter-patient comparisons of DNA damage response biomarkers in Nasopharynx Cancer (NPC): analysis of NCC0901 randomised controlled trial of induction chemotherapy in locally advanced NPC.
    BMC Cancer. 2018;18:1095.
    PubMed     Abstract available


    October 2018
  316. JACINTO AA, Batalha Filho ES, Viana LS, De Marchi P, et al
    Feasibility of concomitant cisplatin with hypofractionated radiotherapy for locally advanced head and neck squamous cell carcinoma.
    BMC Cancer. 2018;18:1026.
    PubMed     Abstract available


  317. LAVACCHI D, Nobili S, Brugia M, Paderi A, et al
    A case report of eyelid Merkel cell carcinoma occurring under treatment with nivolumab for a lung adenocarcinoma.
    BMC Cancer. 2018;18:1024.
    PubMed     Abstract available


  318. BORGGREVE AS, Mook S, Verheij M, Mul VEM, et al
    Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE): a multicenter observational study.
    BMC Cancer. 2018;18:1006.
    PubMed     Abstract available


  319. CHANG W, Tang L, Lu C, Wu M, et al
    Shear wave elastography in the evaluation of level VI lymph nodes in papillary thyroid carcinoma: combined with gray-scale ultrasound ex vivo.
    BMC Cancer. 2018;18:1001.
    PubMed     Abstract available


  320. ONERCI CELEBI O, Sener E, Hosal S, Cengiz M, et al
    Human papillomavirus infection in patients with laryngeal carcinoma.
    BMC Cancer. 2018;18:1005.
    PubMed     Abstract available


  321. XIAO J, Yang W, Xu B, Zhu H, et al
    Expression of fibronectin in esophageal squamous cell carcinoma and its role in migration.
    BMC Cancer. 2018;18:976.
    PubMed     Abstract available


  322. CHO JK, Kim MW, Choi IS, Moon UY, et al
    Optimal cutoff of pretreatment neutrophil-to-lymphocyte ratio in head and neck cancer patients: a meta-analysis and validation study.
    BMC Cancer. 2018;18:969.
    PubMed     Abstract available


  323. KIM SY, Kim SM, Chang HJ, Kim BW, et al
    SoLAT (Sorafenib Lenvatinib alternating treatment): a new treatment protocol with alternating Sorafenib and Lenvatinib for refractory thyroid Cancer.
    BMC Cancer. 2018;18:956.
    PubMed     Abstract available


  324. LIU S, Guo L, Chen Q, Yu L, et al
    The improved cure fraction for esophageal cancer in Linzhou city.
    BMC Cancer. 2018;18:949.
    PubMed     Abstract available


    September 2018
  325. LIU H, Liu Z, Liu XW, Xu S, et al
    A similar effect of P16 hydroxymethylation and true-methylation on the prediction of malignant transformation of oral epithelial dysplasia: observation from a prospective study.
    BMC Cancer. 2018;18:918.
    PubMed     Abstract available


  326. ZHONG L, Liu Y, Wang K, He Z, et al
    Biomarkers: paving stones on the road towards the personalized precision medicine for oral squamous cell carcinoma.
    BMC Cancer. 2018;18:911.
    PubMed     Abstract available


  327. NG SP, Bahig H, Wang J, Cardenas CE, et al
    Predicting treatment Response based on Dual assessment of magnetic resonance Imaging kinetics and Circulating Tumor cells in patients with Head and Neck cancer (PREDICT-HN): matching 'liquid biopsy' and quantitative tumor modeling.
    BMC Cancer. 2018;18:903.
    PubMed     Abstract available


  328. TOMASETTI M, Re M, Monaco F, Gaetani S, et al
    MiR-126 in intestinal-type sinonasal adenocarcinomas: exosomal transfer of MiR-126 promotes anti-tumour responses.
    BMC Cancer. 2018;18:896.
    PubMed     Abstract available


  329. LIU F, Gong R, He B, Chen F, et al
    TUSC2P suppresses the tumor function of esophageal squamous cell carcinoma by regulating TUSC2 expression and correlates with disease prognosis.
    BMC Cancer. 2018;18:894.
    PubMed     Abstract available


  330. ISIDORI F, Malvi D, Fittipaldi S, Forcato C, et al
    Genomic profiles of primary and metastatic esophageal adenocarcinoma identified via digital sorting of pure cell populations: results from a case report.
    BMC Cancer. 2018;18:889.
    PubMed     Abstract available


  331. ZHANG WY, Chen XX, Chen WH, Zhang H, et al
    Nomograms for predicting risk of locoregional recurrence and distant metastases for esophageal cancer patients after radical esophagectomy.
    BMC Cancer. 2018;18:879.
    PubMed     Abstract available


  332. JIN J, He XY
    Basal cell adenocarcinoma of the nasopharyngeal minor salivary glands: a case report and review of the literature.
    BMC Cancer. 2018;18:878.
    PubMed     Abstract available


  333. ZENDA S, Yamaguchi T, Yokota T, Miyaji T, et al
    Topical steroid versus placebo for the prevention of radiation dermatitis in head and neck cancer patients receiving chemoradiotherapy: the study protocol of J-SUPPORT 1602 (TOPICS study), a randomized double-blinded phase 3 trial.
    BMC Cancer. 2018;18:873.
    PubMed     Abstract available


    August 2018
  334. ABBASZADEGAN MR, Taghehchian N, Li L, Aarabi A, et al
    Contribution of KCTD12 to esophageal squamous cell carcinoma.
    BMC Cancer. 2018;18:853.
    PubMed     Abstract available


  335. CHEN YH, Lu HI, Lo CM, Wang YM, et al
    The crucial role of blood VEGF kinetics in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy.
    BMC Cancer. 2018;18:837.
    PubMed     Abstract available


  336. YOKOTA T, Serizawa M, Hosokawa A, Kusafuka K, et al
    PIK3CA mutation is a favorable prognostic factor in esophageal cancer: molecular profile by next-generation sequencing using surgically resected formalin-fixed, paraffin-embedded tissue.
    BMC Cancer. 2018;18:826.
    PubMed     Abstract available


  337. WEHRHAN F, Buttner-Herold M, Distel L, Ries J, et al
    Galectin 3 expression in regional lymph nodes and lymph node metastases of oral squamous cell carcinomas.
    BMC Cancer. 2018;18:823.
    PubMed     Abstract available


  338. CHEN L, Zeng H, Yang J, Lu Y, et al
    Survival and prognostic analysis of preoperative inflammatory markers in patients undergoing surgical resection for laryngeal squamous cell carcinoma.
    BMC Cancer. 2018;18:816.
    PubMed     Abstract available


  339. PUTTIPANYALEARS C, Arayataweegool A, Chalertpet K, Rattanachayoto P, et al
    TRH site-specific methylation in oral and oropharyngeal squamous cell carcinoma.
    BMC Cancer. 2018;18:786.
    PubMed     Abstract available


  340. KORDOWSKI F, Kolarova J, Schafmayer C, Buch S, et al
    Aberrant DNA methylation of ADAMTS16 in colorectal and other epithelial cancers.
    BMC Cancer. 2018;18:796.
    PubMed     Abstract available


  341. OFFMAN J, Muldrew B, O'Donovan M, Debiram-Beecham I, et al
    Barrett's oESophagus trial 3 (BEST3): study protocol for a randomised controlled trial comparing the Cytosponge-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care patients with chronic acid reflux.
    BMC Cancer. 2018;18:784.
    PubMed     Abstract available


    July 2018
  342. MA J, Fu Y, Tu YY, Liu Y, et al
    Mutation allele frequency threshold does not affect prognostic analysis using next-generation sequencing in oral squamous cell carcinoma.
    BMC Cancer. 2018;18:758.
    PubMed     Abstract available


  343. YAO JJ, Jin YN, Wang SY, Zhang F, et al
    The detrimental effects of radiotherapy interruption on local control after concurrent chemoradiotherapy for advanced T-stage nasopharyngeal carcinoma: an observational, prospective analysis.
    BMC Cancer. 2018;18:740.
    PubMed     Abstract available


  344. VAN DER MERWE L, Wan Y, Cheong HJ, Perry C, et al
    A pilot study to profile salivary angiogenic factors to detect head and neck cancers.
    BMC Cancer. 2018;18:734.
    PubMed     Abstract available


  345. WANG J, Liu M, Shen J, Ouyang H, et al
    Diagnostic value of intraoperative ultrasonography in assessing thoracic recurrent laryngeal nerve lymph nodes in patients with esophageal cancer.
    BMC Cancer. 2018;18:737.
    PubMed     Abstract available


  346. LOPES CB, Magalhaes LL, Teofilo CR, Alves APNN, et al
    Differential expression of hsa-miR-221, hsa-miR-21, hsa-miR-135b, and hsa-miR-29c suggests a field effect in oral cancer.
    BMC Cancer. 2018;18:721.
    PubMed     Abstract available


  347. PLATAIS C, Radhakrishnan R, Niklander Ebensperger S, Morgan R, et al
    Targeting HOX-PBX interactions causes death in oral potentially malignant and squamous carcinoma cells but not normal oral keratinocytes.
    BMC Cancer. 2018;18:723.
    PubMed     Abstract available


  348. HWANG-BO J, Bae MG, Park JH, Chung IS, et al
    3-O-Acetyloleanolic acid inhibits VEGF-A-induced lymphangiogenesis and lymph node metastasis in an oral cancer sentinel lymph node animal model.
    BMC Cancer. 2018;18:714.
    PubMed     Abstract available


  349. SOUSA NEVES F, Braga J, Cardoso da Costa J, Sequeira J, et al
    Kaposi's sarcoma of the conjunctiva and the eyelid leads to the diagnosis of human immunodeficiency virus infection - a case report.
    BMC Cancer. 2018;18:708.
    PubMed     Abstract available


    June 2018
  350. TORI M, Shimo T
    Long-term efficacy of lenvatinib for recurrent papillary thyroid carcinoma after multimodal treatment and management of complications: a case report.
    BMC Cancer. 2018;18:698.
    PubMed     Abstract available


  351. THEIN HH, Jembere N, Thavorn K, Chan KKW, et al
    Estimates and predictors of health care costs of esophageal adenocarcinoma: a population-based cohort study.
    BMC Cancer. 2018;18:694.
    PubMed     Abstract available


  352. FU JY, Wu CX, Zhang CP, Gao J, et al
    Oral cancer incidence in Shanghai ---- a temporal trend analysis from 2003 to 2012.
    BMC Cancer. 2018;18:686.
    PubMed     Abstract available


  353. JANG JY, Choi N, Ko YH, Chung MK, et al
    Treatment outcomes in metastatic and localized high-grade salivary gland cancer: high chance of cure with surgery and post-operative radiation in T1-2 N0 high-grade salivary gland cancer.
    BMC Cancer. 2018;18:672.
    PubMed     Abstract available


  354. GRONHOJ C, Jensen DH, Agander T, Kiss K, et al
    Deep sequencing of human papillomavirus positive loco-regionally advanced oropharyngeal squamous cell carcinomas reveals novel mutational signature.
    BMC Cancer. 2018;18:640.
    PubMed     Abstract available


  355. DEZIEL NC, Yi H, Stapleton HM, Huang H, et al
    A case-control study of exposure to organophosphate flame retardants and risk of thyroid cancer in women.
    BMC Cancer. 2018;18:637.
    PubMed     Abstract available


  356. LAI K, Matthews S, Wilmott JS, Killingsworth MC, et al
    Differences in LC3B expression and prognostic implications in oropharyngeal and oral cavity squamous cell carcinoma patients.
    BMC Cancer. 2018;18:624.
    PubMed     Abstract available


    May 2018
  357. ZHANG Y, Chen Y, Liu Z, Lai R, et al
    ERK is a negative feedback regulator for IFN-gamma/STAT1 signaling by promoting STAT1 ubiquitination.
    BMC Cancer. 2018;18:613.
    PubMed     Abstract available


  358. YANG L, Liu L, Han B, Han W, et al
    Apatinib treatment for KIT- and KDR-amplified angiosarcoma: a case report.
    BMC Cancer. 2018;18:618.
    PubMed     Abstract available


  359. YANG XL, Wang Y, Liang SB, He SS, et al
    Comparison of the seventh and eighth editions of the UICC/AJCC staging system for nasopharyngeal carcinoma: analysis of 1317 patients treated with intensity-modulated radiotherapy at two centers.
    BMC Cancer. 2018;18:606.
    PubMed     Abstract available


  360. LUO R, Wu VWC, He B, Gao X, et al
    Development of a normal tissue complication probability (NTCP) model for radiation-induced hypothyroidism in nasopharyngeal carcinoma patients.
    BMC Cancer. 2018;18:575.
    PubMed     Abstract available


  361. KAWAKAMI T, Tsushima T, Omae K, Ogawa H, et al
    Risk factors for esophageal fistula in thoracic esophageal squamous cell carcinoma invading adjacent organs treated with definitive chemoradiotherapy: a monocentric case-control study.
    BMC Cancer. 2018;18:573.
    PubMed     Abstract available


  362. NIE M, Liu C, Pan YC, Jiang CX, et al
    Development and evaluation of oral Cancer quality-of-life questionnaire (QOL-OC).
    BMC Cancer. 2018;18:523.
    PubMed     Abstract available


  363. PENHA RCC, Buexm LA, Rodrigues FR, de Castro TP, et al
    NKX2.5 is expressed in papillary thyroid carcinomas and regulates differentiation in thyroid cells.
    BMC Cancer. 2018;18:498.
    PubMed     Abstract available


  364. WANG H, Luo Q, Feng X, Zhang R, et al
    NLRP3 promotes tumor growth and metastasis in human oral squamous cell carcinoma.
    BMC Cancer. 2018;18:500.
    PubMed     Abstract available


  365. CHEN Y, Tian T, Mao MJ, Deng WY, et al
    CRBP-1 over-expression is associated with poor prognosis in tongue squamous cell carcinoma.
    BMC Cancer. 2018;18:514.
    PubMed     Abstract available


    April 2018
  366. EKIZOGLU S, Seven D, Ulutin T, Guliyev J, et al
    Investigation of the SLC22A23 gene in laryngeal squamous cell carcinoma.
    BMC Cancer. 2018;18:477.
    PubMed     Abstract available


  367. ZICHI C, Tampellini M, Tucci M, Sonetto C, et al
    FOLFOX activity in a rare case of metastatic colonic adenocarcinoma of the tongue: a case report.
    BMC Cancer. 2018;18:470.
    PubMed     Abstract available


  368. ROGERS SN, Lowe D, Lowies C, Yeo ST, et al
    Improving quality of life through the routine use of the patient concerns inventory for head and neck cancer patients: a cluster preference randomized controlled trial.
    BMC Cancer. 2018;18:444.
    PubMed     Abstract available


  369. GAI C, Camussi F, Broccoletti R, Gambino A, et al
    Salivary extracellular vesicle-associated miRNAs as potential biomarkers in oral squamous cell carcinoma.
    BMC Cancer. 2018;18:439.
    PubMed     Abstract available


  370. HUANG XY, Gan RH, Xie J, She L, et al
    The oncogenic effects of HES1 on salivary adenoid cystic carcinoma cell growth and metastasis.
    BMC Cancer. 2018;18:436.
    PubMed     Abstract available


  371. FANG HJ, Shan SB, Zhou YH, Zhong LY, et al
    Diabetes mellitus and the risk of gastrointestinal cancer in women compared with men: a meta-analysis of cohort studies.
    BMC Cancer. 2018;18:422.
    PubMed     Abstract available


  372. FINAZZI T, Rordorf T, Ikenberg K, Huber GF, et al
    Radiotherapy-induced anti-tumor immune response and immune-related adverse events in a case of recurrent nasopharyngeal carcinoma undergoing anti-PD-1 immunotherapy.
    BMC Cancer. 2018;18:395.
    PubMed     Abstract available


  373. JIANYONG L, Zhihui L, Rixiang G, Jingqiang Z, et al
    Using a nomogram based on preoperative serum fibrinogen levels to predict recurrence of papillary thyroid carcinoma.
    BMC Cancer. 2018;18:390.
    PubMed     Abstract available


  374. BARUL C, Carton M, Radoi L, Menvielle G, et al
    Occupational exposure to petroleum-based and oxygenated solvents and hypopharyngeal and laryngeal cancer in France: the ICARE study.
    BMC Cancer. 2018;18:388.
    PubMed     Abstract available


  375. LEUSINK FK, Koudounarakis E, Frank MH, Koole R, et al
    Cathepsin K associates with lymph node metastasis and poor prognosis in oral squamous cell carcinoma.
    BMC Cancer. 2018;18:385.
    PubMed     Abstract available


  376. YU Y, Wang H, Yan A, Wang H, et al
    Pretreatment neutrophil to lymphocyte ratio in determining the prognosis of head and neck cancer: a meta-analysis.
    BMC Cancer. 2018;18:383.
    PubMed     Abstract available


  377. VANNIMENUS C, Bricout H, Le Rouzic O, Mouawad F, et al
    Compared characteristics of current vs. past smokers at the time of diagnosis of a first-time lung or head and neck cancer: a cross-sectional study.
    BMC Cancer. 2018;18:372.
    PubMed     Abstract available


  378. LI XM, Song X, Zhao XK, Hu SJ, et al
    The alterations of cytokeratin and vimentin protein expressions in primary esophageal spindle cell carcinoma.
    BMC Cancer. 2018;18:356.
    PubMed     Abstract available


    March 2018
  379. SETAKORNNUKUL J, Thephamongkhol K
    Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma.
    BMC Cancer. 2018;18:329.
    PubMed     Abstract available


  380. PENG H, Tang LL, Liu X, Chen L, et al
    Anti-EGFR targeted therapy delivered before versus during radiotherapy in locoregionally advanced nasopharyngeal carcinoma: a big-data, intelligence platform-based analysis.
    BMC Cancer. 2018;18:323.
    PubMed     Abstract available


  381. DE ABREU PM, Co ACG, Azevedo PL, do Valle IB, et al
    Frequency of HPV in oral cavity squamous cell carcinoma.
    BMC Cancer. 2018;18:324.
    PubMed     Abstract available


  382. KAUFFMANN RM, Hamner JB, Ituarte PHG, Yim JH, et al
    Age greater than 60 years portends a worse prognosis in patients with papillary thyroid cancer: should there be three age categories for staging?
    BMC Cancer. 2018;18:316.
    PubMed     Abstract available


  383. DU L, Wang Y, Sun X, Li H, et al
    Thyroid cancer: trends in incidence, mortality and clinical-pathological patterns in Zhejiang Province, Southeast China.
    BMC Cancer. 2018;18:291.
    PubMed     Abstract available


  384. SCHLUTER A, Weller P, Kanaan O, Nel I, et al
    CD31 and VEGF are prognostic biomarkers in early-stage, but not in late-stage, laryngeal squamous cell carcinoma.
    BMC Cancer. 2018;18:272.
    PubMed     Abstract available


  385. BROLIH S, Parks SK, Vial V, Durivault J, et al
    AKT1 restricts the invasive capacity of head and neck carcinoma cells harboring a constitutively active PI3 kinase activity.
    BMC Cancer. 2018;18:249.
    PubMed     Abstract available


  386. LU H, Yang S, Zhu H, Tong X, et al
    Targeted next generation sequencing identified clinically actionable mutations in patients with esophageal sarcomatoid carcinoma.
    BMC Cancer. 2018;18:251.
    PubMed     Abstract available


  387. SAKURAMOTO A, Hasegawa Y, Sugahara K, Komoda Y, et al
    New paste for severe stomatitis in patients undergoing head-and-neck cancer radiotherapy and/or chemotherapy with oral appliance.
    BMC Cancer. 2018;18:245.
    PubMed     Abstract available


  388. TAO Y, Gross N, Fan X, Yang J, et al
    Identification of novel enriched recurrent chimeric COL7A1-UCN2 in human laryngeal cancer samples using deep sequencing.
    BMC Cancer. 2018;18:248.
    PubMed     Abstract available


  389. NICKEL B, Brito JP, Moynihan R, Barratt A, et al
    Patients' experiences of diagnosis and management of papillary thyroid microcarcinoma: a qualitative study.
    BMC Cancer. 2018;18:242.
    PubMed     Abstract available


  390. DOVSAK T, Ihan A, Didanovic V, Kansky A, et al
    Effect of surgery and radiotherapy on complete blood count, lymphocyte subsets and inflammatory response in patients with advanced oral cancer.
    BMC Cancer. 2018;18:235.
    PubMed     Abstract available


  391. OKARU AO, Rullmann A, Farah A, Gonzalez de Mejia E, et al
    Comparative oesophageal cancer risk assessment of hot beverage consumption (coffee, mate and tea): the margin of exposure of PAH vs very hot temperatures.
    BMC Cancer. 2018;18:236.
    PubMed     Abstract available


    February 2018
  392. NARVAEZ C, Doemer C, Idel C, Setter C, et al
    Radiotherapy related skin toxicity (RAREST-01): Mepitel(R) film versus standard care in patients with locally advanced head-and-neck cancer.
    BMC Cancer. 2018;18:197.
    PubMed     Abstract available


  393. PEREIRA CM, de Carvalho AC, da Silva FR, Melendez ME, et al
    In vitro and in silico validation of CA3 and FHL1 downregulation in oral cancer.
    BMC Cancer. 2018;18:193.
    PubMed     Abstract available


  394. HU X, Liao J, Zhao H, Chen F, et al
    NBS1 rs2735383 polymorphism is associated with an increased risk of laryngeal carcinoma.
    BMC Cancer. 2018;18:175.
    PubMed     Abstract available


  395. ROHATENSKY MG, Livingstone DM, Mintchev P, Barnes HK, et al
    Assessing the performance of a Loop Mediated Isothermal Amplification (LAMP) assay for the detection and subtyping of high-risk suptypes of Human Papilloma Virus (HPV) for Oropharyngeal Squamous Cell Carcinoma (OPSCC) without DNA purification.
    BMC Cancer. 2018;18:166.
    PubMed     Abstract available


  396. JAYARAJAH U, Fernando A, Prabashani S, Fernando EA, et al
    Incidence and histological patterns of thyroid cancer in Sri Lanka 2001-2010: an analysis of national cancer registry data.
    BMC Cancer. 2018;18:163.
    PubMed     Abstract available


  397. HUANG GW, Xue YJ, Wu ZY, Xu XE, et al
    A three-lncRNA signature predicts overall survival and disease-free survival in patients with esophageal squamous cell carcinoma.
    BMC Cancer. 2018;18:147.
    PubMed     Abstract available


  398. HARADA K, Ferdous T, Ueyama Y
    PD-L1 expression in malignant salivary gland tumors.
    BMC Cancer. 2018;18:156.
    PubMed     Abstract available


  399. NOORDMAN BJ, Wijnhoven BPL, Lagarde SM, Boonstra JJ, et al
    Neoadjuvant chemoradiotherapy plus surgery versus active surveillance for oesophageal cancer: a stepped-wedge cluster randomised trial.
    BMC Cancer. 2018;18:142.
    PubMed     Abstract available


  400. MARIETTE C, Renaud F, Piessen G, Gele P, et al
    The FREGAT biobank: a clinico-biological database dedicated to esophageal and gastric cancers.
    BMC Cancer. 2018;18:139.
    PubMed     Abstract available


  401. PENSABENE M, Stanzione B, Cerillo I, Ciancia G, et al
    It is no longer the time to disregard thyroid metastases from breast cancer: a case report and review of the literature.
    BMC Cancer. 2018;18:146.
    PubMed     Abstract available


  402. AL-KHYATT W, Tufarelli C, Khan R, Iftikhar SY, et al
    Selective oestrogen receptor antagonists inhibit oesophageal cancer cell proliferation in vitro.
    BMC Cancer. 2018;18:121.
    PubMed     Abstract available


    January 2018
  403. GUO SS, Hu W, Chen QY, Li JM, et al
    Pretreatment quality of life as a predictor of survival for patients with nasopharyngeal carcinoma treated with IMRT.
    BMC Cancer. 2018;18:114.
    PubMed     Abstract available


  404. CELESTINO R, Nome T, Pestana A, Hoff AM, et al
    CRABP1, C1QL1 and LCN2 are biomarkers of differentiated thyroid carcinoma, and predict extrathyroidal extension.
    BMC Cancer. 2018;18:68.
    PubMed     Abstract available


  405. BARROS FBA, Assao A, Garcia NG, Nonogaki S, et al
    Moesin expression by tumor cells is an unfavorable prognostic biomarker for oral cancer.
    BMC Cancer. 2018;18:53.
    PubMed     Abstract available


  406. NAMANI A, Matiur Rahaman M, Chen M, Tang X, et al
    Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer.
    BMC Cancer. 2018;18:46.
    PubMed     Abstract available


  407. GAO SG, Yang JQ, Ma ZK, Yuan X, et al
    Preoperative serum immunoglobulin G and A antibodies to Porphyromonas gingivalis are potential serum biomarkers for the diagnosis and prognosis of esophageal squamous cell carcinoma.
    BMC Cancer. 2018;18:17.
    PubMed     Abstract available


  408. MAO MJ, Xue N, Wang XP, Chi PD, et al
    Chemokine CCL27 is a novel plasma biomarker for identification the nasopharyngeal carcinoma patients from the Epstein-Barr virus capsid antigen-specific IgA seropositive population.
    BMC Cancer. 2018;18:9.
    PubMed     Abstract available


  409. PATTERSON JM, Fay M, Exley C, McColl E, et al
    Feasibility and acceptability of combining cognitive behavioural therapy techniques with swallowing therapy in head and neck cancer dysphagia.
    BMC Cancer. 2018;18:1.
    PubMed     Abstract available


    December 2017
  410. KIM SY, Rho YS, Choi EC, Kim MS, et al
    Clinicopathological factors influencing the outcomes of surgical treatment in patients with T4a hypopharyngeal cancer.
    BMC Cancer. 2017;17:904.
    PubMed     Abstract available


  411. CHEN J, Li S, Xiao Y, Zou X, et al
    p53R2 as a novel prognostic biomarker in nasopharyngeal carcinoma.
    BMC Cancer. 2017;17:846.
    PubMed     Abstract available


  412. PRITCHETT NR, Burgert SL, Murphy GA, Brockman JD, et al
    Cross sectional study of serum selenium concentration and esophageal squamous dysplasia in western Kenya.
    BMC Cancer. 2017;17:835.
    PubMed     Abstract available


  413. QUINTANILHA JCF, Visacri MB, Amaral LS, Lima CSP, et al
    Leukocytoclastic vasculitis complicating cisplatin + radiation treatment for laryngeal cancer: a case report.
    BMC Cancer. 2017;17:831.
    PubMed     Abstract available


  414. KANO K, Aoyama T, Nakajima T, Maezawa Y, et al
    Prediction of postoperative inflammatory complications after esophageal cancer surgery based on early changes in the C-reactive protein level in patients who received perioperative steroid therapy and enhanced recovery after surgery care: a retrospect
    BMC Cancer. 2017;17:812.
    PubMed     Abstract available


    November 2017
  415. SHAIKH MH, Khan AI, Sadat A, Chowdhury AH, et al
    Prevalence and types of high-risk human papillomaviruses in head and neck cancers from Bangladesh.
    BMC Cancer. 2017;17:792.
    PubMed     Abstract available


  416. ZHANG LL, Zhou GQ, Qi ZY, He XJ, et al
    Patient- and treatment-related risk factors associated with neck muscle spasm in nasopharyngeal carcinoma patients after intensity-modulated radiotherapy.
    BMC Cancer. 2017;17:788.
    PubMed     Abstract available


  417. HIGUCHI Y, Motoki T, Ishida H, Kanamitsu K, et al
    Sorafenib treatment for papillary thyroid carcinoma with diffuse lung metastases in a child with autism spectrum disorder: a case report.
    BMC Cancer. 2017;17:775.
    PubMed     Abstract available


  418. MURAKAMI M, Otsuka K, Goto S, Ariyoshi T, et al
    Thoracoscopic and hand assisted laparoscopic esophagectomy with radical lymph node dissection for esophageal squamous cell carcinoma in the left lateral decubitus position: a single center retrospective analysis of 654 patients.
    BMC Cancer. 2017;17:748.
    PubMed     Abstract available


  419. JIN Y, Liu M, Cheng L, Chen L, et al
    Successful pregnancy without disease progression of radioiodine refractory papillary thyroid carcinoma: a case report.
    BMC Cancer. 2017;17:735.
    PubMed     Abstract available


  420. DI L, Fu KI, Xie R, Wu X, et al
    A modified endoscopic submucosal dissection for a superficial hypopharyngeal cancer: a case report and technical discussion.
    BMC Cancer. 2017;17:712.
    PubMed     Abstract available


    October 2017
  421. ROCHA TAH, Thomaz EBAF, da Silva NC, de Sousa Queiroz RC, et al
    Oral primary care: an analysis of its impact on the incidence and mortality rates of oral cancer.
    BMC Cancer. 2017;17:706.
    PubMed     Abstract available


  422. NIE X, Tan Z, Ge M
    Skip metastasis in papillary thyroid carcinoma is difficult to predict in clinical practice.
    BMC Cancer. 2017;17:702.
    PubMed     Abstract available


  423. YAN DF, Zhang WB, Ke SB, Zhao F, et al
    The prognostic value of pretreatment tumor apparent diffusion coefficient values in nasopharyngeal carcinoma.
    BMC Cancer. 2017;17:678.
    PubMed     Abstract available


    September 2017
  424. MA X, Xia QJ, Li G, Wang TX, et al
    Aesthetic principles access thyroidectomy produces the best cosmetic outcomes as assessed using the patient and observer scar assessment scale.
    BMC Cancer. 2017;17:654.
    PubMed     Abstract available


  425. REYNOLDS KL, Bedard PL, Lee SH, Lin CC, et al
    A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer.
    BMC Cancer. 2017;17:646.
    PubMed     Abstract available


  426. YANG L, Xia L, Wang Y, He S, et al
    Development and external validation of nomograms to predict the risk of skeletal metastasis at the time of diagnosis and skeletal metastasis-free survival in nasopharyngeal carcinoma.
    BMC Cancer. 2017;17:628.
    PubMed     Abstract available


  427. DYCKHOFF G, Plinkert PK, Ramroth H
    A change in the study evaluation paradigm reveals that larynx preservation compromises survival in T4 laryngeal cancer patients.
    BMC Cancer. 2017;17:609.
    PubMed     Abstract available


    August 2017
  428. DU L, Zhang XX, Feng LC, Qu BL, et al
    Propensity score matching analysis of a phase II study on simultaneous modulated accelerated radiation therapy using helical tomotherapy for nasopharyngeal carcinomas.
    BMC Cancer. 2017;17:582.
    PubMed     Abstract available


  429. CHRISTENSEN A, Kiss K, Lelkaitis G, Juhl K, et al
    Urokinase-type plasminogen activator receptor (uPAR), tissue factor (TF) and epidermal growth factor receptor (EGFR): tumor expression patterns and prognostic value in oral cancer.
    BMC Cancer. 2017;17:572.
    PubMed     Abstract available


  430. LI Y, Chen QY, Tang LQ, Liu LT, et al
    Concurrent chemoradiotherapy with or without cetuximab for stage II to IVb nasopharyngeal carcinoma: a case-control study.
    BMC Cancer. 2017;17:567.
    PubMed     Abstract available


  431. VAN VULPEN JK, Siersema PD, van Hillegersberg R, Nieuwenhuijzen GAP, et al
    Physical ExeRcise Following Esophageal Cancer Treatment (PERFECT) study: design of a randomized controlled trial.
    BMC Cancer. 2017;17:552.
    PubMed     Abstract available


  432. HUANG H, Wang XP, Li XH, Chen H, et al
    Prognostic value of pretreatment serum alanine aminotransferase/aspartate aminotransferase (ALT/AST) ratio and gamma glutamyltransferase (GGT) in patients with esophageal squamous cell carcinoma.
    BMC Cancer. 2017;17:544.
    PubMed     Abstract available


    July 2017
  433. HAAG GM, Stocker G, Quidde J, Jaeger D, et al
    Randomized controlled trial of S-1 maintenance therapy in metastatic esophagogastric cancer - the multinational MATEO study.
    BMC Cancer. 2017;17:509.
    PubMed     Abstract available


  434. LIANG SB, Teng JJ, Hu XF, Yang XL, et al
    Prognostic value of total tumor volume in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.
    BMC Cancer. 2017;17:506.
    PubMed     Abstract available


  435. LAI J, Xu P, Jiang X, Zhou S, et al
    Successful treatment with anti-programmed-death-1 antibody in a relapsed natural killer/T-cell lymphoma patient with multi-line resistance: a case report.
    BMC Cancer. 2017;17:507.
    PubMed     Abstract available


  436. ZHAO W, Mo Y, Wang S, Midorikawa K, et al
    Quantitation of DNA methylation in Epstein-Barr virus-associated nasopharyngeal carcinoma by bisulfite amplicon sequencing.
    BMC Cancer. 2017;17:489.
    PubMed     Abstract available


  437. GUAN H, Guo Z, Liang W, Li H, et al
    Trop2 enhances invasion of thyroid cancer by inducing MMP2 through ERK and JNK pathways.
    BMC Cancer. 2017;17:486.
    PubMed     Abstract available


  438. SERVAGI-VERNAT S, Crehange G, Bonnetain F, Mertens C, et al
    Chemoradiation in elderly esophageal cancer patients: rationale and design of a phase I/II multicenter study (OSAGE).
    BMC Cancer. 2017;17:483.
    PubMed     Abstract available


  439. FU X, Shen C, Wang H, Chen F, et al
    Joint quantitative measurement of hTERT mRNA in both peripheral blood and circulating tumor cells of patients with nasopharyngeal carcinoma and its clinical significance.
    BMC Cancer. 2017;17:479.
    PubMed     Abstract available


  440. SU Y, Yu QH, Wang XY, Yu LP, et al
    JMJD2A promotes the Warburg effect and nasopharyngeal carcinoma progression by transactivating LDHA expression.
    BMC Cancer. 2017;17:477.
    PubMed     Abstract available


  441. RUMLEY CN, Lee MT, Holloway L, Rai R, et al
    Multiparametric magnetic resonance imaging in mucosal primary head and neck cancer: a prospective imaging biomarker study.
    BMC Cancer. 2017;17:475.
    PubMed     Abstract available


    June 2017
  442. YU X, Li W, Xia Z, Xie L, et al
    Targeting MCL-1 sensitizes human esophageal squamous cell carcinoma cells to cisplatin-induced apoptosis.
    BMC Cancer. 2017;17:449.
    PubMed     Abstract available


  443. TANG H, Tan L, Shen Y, Wang H, et al
    CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous
    BMC Cancer. 2017;17:450.
    PubMed     Abstract available


  444. IMANISHI Y, Ozawa H, Sakamoto K, Fujii R, et al
    Clinical outcomes of transoral videolaryngoscopic surgery for hypopharyngeal and supraglottic cancer.
    BMC Cancer. 2017;17:445.
    PubMed     Abstract available


  445. ERKIZAN HV, Johnson K, Ghimbovschi S, Karkera D, et al
    African-American esophageal squamous cell carcinoma expression profile reveals dysregulation of stress response and detox networks.
    BMC Cancer. 2017;17:426.
    PubMed     Abstract available


  446. VAN GINKEL JH, Huibers MMH, van Es RJJ, de Bree R, et al
    Droplet digital PCR for detection and quantification of circulating tumor DNA in plasma of head and neck cancer patients.
    BMC Cancer. 2017;17:428.
    PubMed     Abstract available


  447. LONKVIST CK, Lonbro S, Vinther A, Zerahn B, et al
    Progressive resistance training in head and neck cancer patients during concomitant chemoradiotherapy -- design of the DAHANCA 31 randomized trial.
    BMC Cancer. 2017;17:400.
    PubMed     Abstract available


  448. REYNOLDS JV, Preston SR, O'Neill B, Baeksgaard L, et al
    ICORG 10-14: NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS).
    BMC Cancer. 2017;17:401.
    PubMed     Abstract available


    May 2017
  449. KREYCY N, Gotzian C, Fleming T, Flechtenmacher C, et al
    Glyoxalase 1 expression is associated with an unfavorable prognosis of oropharyngeal squamous cell carcinoma.
    BMC Cancer. 2017;17:382.
    PubMed     Abstract available


  450. HASEGAWA H, Kusumi Y, Asakawa T, Maeda M, et al
    Expression of von Hippel-Lindau tumor suppressor protein (pVHL) characteristic of tongue cancer and proliferative lesions in tongue epithelium.
    BMC Cancer. 2017;17:381.
    PubMed     Abstract available


  451. FANG J, Li X, Ma D, Liu X, et al
    Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.
    BMC Cancer. 2017;17:375.
    PubMed     Abstract available


  452. OLUIC B, Paunovic I, Loncar Z, Djukic V, et al
    Survival and prognostic factors for survival, cancer specific survival and disease free interval in 239 patients with Hurthle cell carcinoma: a single center experience.
    BMC Cancer. 2017;17:371.
    PubMed     Abstract available


  453. MAGNUSSEN SN, Hadler-Olsen E, Costea DE, Berg E, et al
    Cleavage of the urokinase receptor (uPAR) on oral cancer cells: regulation by transforming growth factor - beta1 (TGF-beta1) and potential effects on migration and invasion.
    BMC Cancer. 2017;17:350.
    PubMed     Abstract available


  454. KULASINGHE A, Perry C, Kenny L, Warkiani ME, et al
    PD-L1 expressing circulating tumour cells in head and neck cancers.
    BMC Cancer. 2017;17:333.
    PubMed     Abstract available


  455. LONJOU C, Damiola F, Moissonnier M, Durand G, et al
    Investigation of DNA repair-related SNPs underlying susceptibility to papillary thyroid carcinoma reveals MGMT as a novel candidate gene in Belarusian children exposed to radiation.
    BMC Cancer. 2017;17:328.
    PubMed     Abstract available


  456. DEMOOR-GOLDSCHMIDT C, Drui D, Doutriaux I, Michel G, et al
    A French national breast and thyroid cancer screening programme for survivors of childhood, adolescent and young adult (CAYA) cancers - DeNaCaPST programme.
    BMC Cancer. 2017;17:326.
    PubMed     Abstract available


  457. YOKOTA T, Ogawa T, Takahashi S, Okami K, et al
    Efficacy and safety of rebamipide liquid for chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II study.
    BMC Cancer. 2017;17:314.
    PubMed     Abstract available


    April 2017
  458. ZHAO H, Wang Y, Wang MJ, Zhang ZH, et al
    Influence of presence/absence of thyroid gland on the cutoff value for thyroglobulin in lymph-node aspiration to detect metastatic papillary thyroid carcinoma.
    BMC Cancer. 2017;17:296.
    PubMed     Abstract available


  459. LIN CL, Lee WT, Ou CY, Hsiao JR, et al
    Regular recreational physical activity and risk of head and neck cancer.
    BMC Cancer. 2017;17:286.
    PubMed     Abstract available


  460. WAGNER M, Khoury H, Bennetts L, Berto P, et al
    Appraising the holistic value of Lenvatinib for radio-iodine refractory differentiated thyroid cancer: A multi-country study applying pragmatic MCDA.
    BMC Cancer. 2017;17:272.
    PubMed     Abstract available


  461. GREUTER MJ, Schouten CS, Castelijns JA, de Graaf P, et al
    Cost-effectiveness of response evaluation after chemoradiation in patients with advanced oropharyngeal cancer using 18F-FDG-PET-CT and/or diffusion-weighted MRI.
    BMC Cancer. 2017;17:256.
    PubMed     Abstract available


  462. XIONG L, Zeng XL, Guo CK, Liu AW, et al
    Optimal treatment and prognostic factors for esthesioneuroblastoma: retrospective analysis of 187 Chinese patients.
    BMC Cancer. 2017;17:254.
    PubMed     Abstract available


    March 2017
  463. VARADARAJAN VV, Pace EK, Patel V, Sawhney R, et al
    Follicular thyroid carcinoma metastasis to the facial skeleton: a systematic review.
    BMC Cancer. 2017;17:225.
    PubMed     Abstract available


  464. VAN DEN BOSCH S, Dijkema T, Kunze-Busch MC, Terhaard CH, et al
    Uniform FDG-PET guided GRAdient Dose prEscription to reduce late Radiation Toxicity (UPGRADE-RT): study protocol for a randomized clinical trial with dose reduction to the elective neck in head and neck squamous cell carcinoma.
    BMC Cancer. 2017;17:208.
    PubMed     Abstract available


    February 2017
  465. KOMAKI K, Kusaba T, Tanaka M, Kado H, et al
    Lower blood pressure and risk of cisplatin nephrotoxicity: a retrospective cohort study.
    BMC Cancer. 2017;17:144.
    PubMed     Abstract available


  466. BRADLEY NL, Wiseman SM
    Papillary thyroid microcarcinoma: the significance of high risk features.
    BMC Cancer. 2017;17:142.
    PubMed     Abstract available


  467. CHO YJ, Kim DY, Park EC, Han KT, et al
    Thyroid fine-needle aspiration biopsy positively correlates with increased diagnosis of thyroid cancer in South Korean patients.
    BMC Cancer. 2017;17:114.
    PubMed     Abstract available


    January 2017
  468. MORITA FH, Bernardo WM, Ide E, Rocha RS, et al
    Narrow band imaging versus lugol chromoendoscopy to diagnose squamous cell carcinoma of the esophagus: a systematic review and meta-analysis.
    BMC Cancer. 2017;17:54.
    PubMed     Abstract available


  469. LIN MC, Lin YC, Chen ST, Young TH, et al
    Therapeutic vaccine targeting Epstein-Barr virus latent protein, LMP1, suppresses LMP1-expressing tumor growth and metastasis in vivo.
    BMC Cancer. 2017;17:18.
    PubMed     Abstract available


  470. SONG H, Fang F, Valdimarsdottir U, Lu D, et al
    Waiting time for cancer treatment and mental health among patients with newly diagnosed esophageal or gastric cancer: a nationwide cohort study.
    BMC Cancer. 2017;17:2.
    PubMed     Abstract available


    January 2016
  471. BRENNAN K, Holsinger C, Dosiou C, Sunwoo JB, et al
    Development of prognostic signatures for intermediate-risk papillary thyroid cancer.
    BMC Cancer. 2016;16:736.
    PubMed     Abstract available


  472. HARADA K, Ferdous T, Cui D, Kuramitsu Y, et al
    Induction of artificial cancer stem cells from tongue cancer cells by defined reprogramming factors.
    BMC Cancer. 2016;16:548.
    PubMed     Abstract available


  473. CARLBERG M, Hedendahl L, Ahonen M, Koppel T, et al
    Increasing incidence of thyroid cancer in the Nordic countries with main focus on Swedish data.
    BMC Cancer. 2016;16:426.
    PubMed     Abstract available


  474. MARITAZ C, Metz C, Baba-Hamed N, Jardin-Szucs M, et al
    Cetuximab-induced aseptic meningitis: case report and review of a rare adverse event.
    BMC Cancer. 2016;16:384.
    PubMed     Abstract available


  475. VOJTECHOVA Z, Sabol I, Salakova M, Smahelova J, et al
    Comparison of the miRNA profiles in HPV-positive and HPV-negative tonsillar tumors and a model system of human keratinocyte clones.
    BMC Cancer. 2016;16:382.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: